Category: ACN Newswire

MUNICH, GERMANY | DRESDEN, GERMANY | TEL AVIV, ISRAEL, Dec 4, 2024 - (ACN Newswire via SeaPRwire.com) - Autobrains, a leader in automotive artificial intelligence (AI), has joined forces with JOYNEXT, a global automotive Tier-1 supplier and development partner to renowned car manufacturers for over 20 years, to offer their groundbreaking Smart Camera ADAS solution. The camera hardware and optimized control software, provided by JOYNEXT, is powered by Autobrains' Affordable Safety ADAS software. The single-box Smart Camera solution, optimized for cost-effective Advanced Driver Assistance Systems (ADAS), was designed to meet the evolving needs of global Original Equipment Manufacturers (OEMs). This compact system simplifies integration, reduces costs, and ensures regulatory compliance without sacrificing performance.With ever increasing global regulations, smart cameras are a must-have in new build vehicles. The joint Smart Camera meets stringent global safety standards, including Europe's General Safety Regulation (GSR) and Euro NCAP requirements, ensuring its readiness for widespread deployment across vehicle classes. "Building a powerful ecosystem is crucial in order to be able to offer our global customers reliable and future-oriented technologies," says Stavros Mitrakis, CEO of JOYNEXT GmbH. "Autobrains is a fitting partner. With them, we will be able to offer reliable, high-quality, and cost-effective technologies in the field of automated driving in the future."Affordable Safety AI Software"Our new Affordable Safety ADAS solution leverages Autobrains' signature-based self-learning Liquid AI technology, delivering unparalleled efficiency and significantly lowering training, validation, and BOM (Bill of Materials) costs," explains Igal Raichelgauz, Founder and CEO of Autobrains. "By indexing and compressing data into sparse binary representations, the AI system requires less computational power, reducing the size and cost of the SoC (System-on-Chip) and sensor needed for operation." Autobrains' Liquid AI mimics human brain functionality, reducing reliance on labeled data, accelerating development cycles, and minimizing data bias. This hardware-agnostic solution offers OEMs the flexibility to integrate it into existing hardware environments, making ADAS accessible to a wider range of vehicles, from premium models to compact cars, without compromising safety or performance.ADAS as a Standard FeatureDriver assistance systems are becoming standard in all vehicle segments and regions thanks to stronger regulations and NCAP safety ratings. "Providing these assistance systems cost-efficiently to car manufacturers and drivers is a challenge for the industry," says Manuel Yoon, General Manager Germany and VP Strategy of Autobrains. "Our contribution is to help reduce the number of accidents by providing technology that enables autonomous emergency braking, lane-keeping support, and intelligent speed assistants for everyone. In addition, we can reduce the drivers' burden with comfort features such as adaptive cruise control with a single camera."Streamlined ScalabilityThe system eliminates the need for complex multi-component systems, reducing time-to-market while enhancing scalability. "Our smart camera combines data collection, processing and control in one compact device. There are expansion stages with an additional interior camera, which means the system can also meet driver monitoring requirements within a single module. This makes our products an attractive solution, especially for European and Asian OEMs." emphasizes Jan Kolanko, Senior Manager for ADAS at JOYNEXT GmbH.The new Smart Camera ADAS solution will be available for OEMs worldwide starting in early 2025. This groundbreaking solution aims to democratize advanced safety technologies, making them accessible to a broader range of vehicles and markets.For more information about Autobrains and its innovative AI solutions, please visit www.autobrains.ai.Autobrains - We Drive AIAutobrains is a leading AI company in the automotive industry. Autobrains invented and developed a paradigm-shifting AI technology: Liquid AI - backed by 250+ patents addressing autonomous driving challenges. Implementing this unique AI technology for ADAS applications disrupts the market with its unprecedented perception capabilities, low compute requirements, and agnosicity to sensors and SoCs. The company is backed by strategic investors including Temasek, Knorr-Bremse, BMW i Ventures, Toyota Ventures, VinFast, Continental, and Autel.JOYNEXT - WE CONNECT FUTUREIntelligent solutions for connected vehicles - that's JOYNEXT. We are working on future technologies that are becoming increasingly important for car manufacturers and their customers. On the road to autonomous driving, data communication between the vehicle and mobile devices such as smartphones, with other vehicles (V2V) or with infrastructure systems (V2I) is becoming increasingly important. JOYNEXT is also involved in the new and further development of cloud-based services.JOYNEXT always strives for a balance between innovation and sustainability. When developing our products, we focus on the end user and their needs and usage behavior.With more than 1,500 employees worldwide, JOYNEXT takes connected car technologies to a new level. We are present at seven locations; our development and innovation centers are located in Dresden (Germany) and Ningbo (China).JOYNEXT is a direct supplier to the automotive industry and has been a development partner and system supplier to renowned car manufacturers for over 20 years. Our technologies in the areas of connected infotainment and smart connectivity gateways can be found in millions of vehicles worldwide. www.JOYNEXT.comContact InformationSophia EichlerDirector of Marketingmedia@autobrains.ai+49 15167066494Source: Autobrains Copyright 2024 ACN Newswire via SeaPRwire.com.

HONG KONG, Dec 4, 2024 - (ACN Newswire via SeaPRwire.com) – CITIC Telecom International CPC Limited (“CITIC Telecom CPC”), a wholly-owned subsidiary of CITIC Telecom International Holdings Limited (SEHK: 1883) is pleased to announce the winning of three industry awards, affirming CITIC Telecom CPC’s unwavering commitment to cybersecurity excellence, recognizing the deep industry expertise of its professional team, strong cybersecurity awareness among its workforce and cutting-edge innovative solutions to meet the growing cybersecurity demand and combat the increasingly rampant cyber threats and challenges.The three industry awards are:- Hong Kong Internet Registration Corporation Limited (HKIRC) - Platinum Award in Cyber Security Staff Awareness Recognition Scheme 2024;- Top Managed Security Service Provider (MSSP) of the Year 2024, by Fortinet;- Top Partner Enterprise Business FY24, by Green RadarMr. Brook Wong, Chief Executive Officer of CITIC Telecom CPC, said, “The three industry accolades are a testament to our commitment to foster internal ‘Human Firewall’ culture in our company while providing cutting-edge security solutions externally through our cybersecurity experts, showcasing our solid foundation in both internal and external cybersecurity excellence. These industry recognitions inspire us to further elevate cybersecurity awareness and innovative solutions, unleashing more market opportunities and jointly nurturing high-quality industry development. We lead the market with our dedicated approach to promoting advanced security solutions "TrustCSI™ 3.0", solidifying our position as a cybersecurity leader in digital defense.” HKIRC Cyber Security Staff Awareness Recognition SchemeCo-organized by The Hong Kong Internet Registration Corporation Limited (HKIRC) and ISACA China Hong Kong Chapter (ISACA), Cyber Security Staff Awareness Recognition Scheme was completed. Participating organizations include SMEs and large enterprises in banking, property management, retail and other industries. The Scheme aims to recognize organizations that are aware of the importance and have implemented suitable measures to enhance cybersecurity staff awareness within their organizations in the past 12 months. The Scheme enhances organizations’ protection level by encouraging the organizations to promote “Human Firewall” concept through multiple channels such as training, policy, communication, drill, etc. The top-tier Platinum Award requires the fulfilment of all the five assessment criteria including cybersecurity training, phishing drill participation, comprehensive cybersecurity policy, reporting channels for cybersecurity issues and dissemination of cybersecurity information.CITIC Telecom CPC has clinched the prestigious Platinum Award in recognition of its dedication to enhancing network security technologies, comprehensive optimiziation of systems and policies, and the introduction of "TrustCSI™ 3.0" cybersecurity solution, innovative service framework and proactive defense technologies to respond to ever-increasing network threats. CITIC Telecom CPC also cultivates a culture of cybersecurity awareness among its staff through global staff training and cybersecurity drills, building a second level of defense line for the company to defend and effectively address ever-changing security threats. Collaborate to Succeed: Building a Robust Defense EcosystemsCITIC Telecom CPC achieved various prestigious awards from two cybersecurity ecosystem partners Fortinet and Green Radar, demonstrating its excellent collaboration capabilities in global cooperation strategies and cybersecurity. CITIC Telecom CPC has not only met the market demand for cybersecurity solutions, but also surpassed competitors through continuous technological innovations and close collaborations with ecosystem partners, including the launch of "TrustCSI™ 3.0" cybersecurity solutions in 2023, which enhances the core service capabilities of the Security Operations Center (SOC) to provide enterprises with proactive defense, integrate AI applications into their business, and optimize their intelligent operations.CITIC Telecom CPC has been bestowed "Top Managed Security Service Provider of the Year 2024" by Fortinet, a testament to the company's excellence in providing cutting-edge managed security services that exceed industry standards. In addition, CITIC Telecom CPC has been recognized as the "Top Partner Enterprise Business FY24" by Green Radar, which underscores CITIC Telecom CPC's strategic collaborations with partners to provide innovative solutions to address unique cybersecurity needs of enterprise clients.Proactively Elevating Network Security and Innovative Technologies Internally and ExternallyCITIC Telecom CPC actively pursues excellent cybersecurity capabilities, both internally and externally. Internally, CPC fosters a culture of cybersecurity awareness. Its staff have demonstrated cybersecurity best practices by always staying vigilant and employing proactive defense in the workplace, thus safeguarding the company’s digital assets. Externally, CITIC Telecom CPC is committed to be a trusted TechOps Security Enabler for enterprises. With a passion for innovation and excellence, its cybersecurity experts team provides professional services and tailored innovative solutions, empowering enterprises to navigate the digital landscape with confidence and resilience.With the motto “Innovation Never Stops”, CITIC Telecom CPC continues to integrate AI technology into its information security products portfolio to provide advanced cybersecurity solutions for addressing the evolving network threats. The newly-launched TrustCSI™ AI Pentest service functions as an AI robot cleaner which automatically operates 24x7, helping enterprises identify key vulnerabilities in the network and establish a robust defense against potential threats. CITIC Telecom CPC introduces a special offer which includes TrustCSI™ AI Pentest and Attack Surface Management (ASM) for internal and external vulnerabilities scanning, enhancing customers’ resistance to vulnerabilities and systematically improving identification, prioritization and remediation of vulnerabilities, and continuous monitoring of hacking attempts. Enterprise security management strategy can be elevated through multiple defense measures to mitigate potential network attack risks. For special offer details, please visit https://www1.citictel-cpc.com/promotion/2411XmasOffer/index-EN.html.About CITIC Telecom CPCWe are CITIC Telecom International CPC Limited (“CITIC Telecom CPC”), a wholly-owned subsidiary of CITIC Telecom International Holdings Limited (SEHK: 1883), serving multinational enterprises the world over by addressing their specific ICT requirements with highly scalable tailored solutions built upon our flagship technology suites, comprising TrueCONNECT™ private network solutions, TrustCSI™ information security solutions, DataHOUSE™ cloud data center solutions, and SmartCLOUD™ cloud computing solutions.With the motto “Innovation Never Stops,” we leverage innovative technologies to boost technology empowerment (+AI). Embracing AI, AR, Big Data, IoT, and other cutting-edge emerging technologies we aim to unlock technical potential. By integrating deep learning and intelligent data analysis technologies, we transform these technologies into data empowerment (AI+) generative applications, reshaping the Intelligence Operation Journey of enterprises.With our Global-Local capabilities, we are committed to providing our customers with one-stop-shop ICT solutions with superior quality. Having a worldwide footprint across nearly 160 countries and regions, including Asia, Europe and America, Africa, the Middle East, and Central Asia, our global network resources connect nearly 170 points of presence (POPs), 60+ SDWAN gateways, 21 Cloud service centers, 30+ data centers, and three dedicated 24x7 Security Operations Centers (SOCs). We are certified with a series of international certifications, including SD-WAN Ready, ISO 9001, 14001, 20000, 27001, and 27017, to ensure our services compliance with international standards and resources for enterprises. We offer local professional services, superior delivery capabilities as well as exceptional customer experience and best practices through our global presence and extensive industry know-how, becoming a leading integrated intelligent ICT service provider to enterprise customers. For more information, please visit www.citictel-cpc.com.Media Contacts:Catherine YuenCITIC Telecom CPC(852) 2170 7536Email: catherine.yuen@citictel-cpc.com Copyright 2024 ACN Newswire via SeaPRwire.com.

Delaware, USA, Dec 4, 2024 - (ACN Newswire via SeaPRwire.com) - As the digital world is increasingly threatened by advanced cyberattacks and looming quantum computing challenges, Naoris Protocol unveils groundbreaking technology that revolutionizes digital security through the world's first Post-Quantum powered Decentralized Physical Infrastructure Network (DePIN) for cybersecurity and digital trust.Backed by prominent figures including DNS designer David Holtzman, former White House Chief of Staff Mick Mulvaney, and Shanfari & Partners Chairman H.E. Sheikh Thamer Said Ahmed al-Shanfari, this innovative protocol transforms traditional untrusted devices into a decentralized security layer of cyber-trusted validator nodes, eliminating single points of failure that plague centralized security systems.Decentralized Security: A Necessary Shift Amidst Rising Centralized FailuresThe launch comes at a critical time, following the CrowdStrike outages in July 2024 that demonstrated the vulnerabilities of centralized security frameworks. These incidents disrupted global services across aviation, banking, and media sectors, highlighting the urgent need for decentralized security solutions."Current centralized models are vulnerable by design," states David Carvalho, CEO & Founder of Naoris Protocol."Our protocol decentralizes digital security, where every device becomes a secure validator node as part of a trusted, incentivized layer that uses post-quantum cryptography to create a real time, decentralized validation brain."The protocol introduces four key innovations:Post-Quantum Security: Designed to withstand quantum computing, ensuring sensitive data and blockchain infrastructures are protected from next-generation cyber threats.Decentralized Security Layer: Devices actively validate and prove their trusted state in real time, creating a self-reinforcing security layer that scales without weakening.Incentivized Security Model: Devices are rewarded for maintaining security validations across the network to continually reinforce cyber defenses.Real-Time Validation: Continuous verification of node integrity mitigates risks of compromise or collusion, a stark contrast to static and reactive centralized systems.Impact on Expanding DePIN EcosystemsWith the DePIN market projected to reach $3.5 trillion by 2028, Naoris Protocol positions itself as the critical security DePIN for both Web2 and Web3 infrastructures. As DePIN expands into various industrial applications, the protocol provides essential infrastructure for DePIN ecosystems across cloud computing, storage, wireless and energy, offering unprecedented cyber resilience for community compute network models.DNS pioneer David Holtzman, serving as Chief Strategy Officer, emphasizes: "Naoris Protocol is not just another blockchain project; it's the security backbone that enables the entire DePIN sector to thrive safely. This could be the catalyst that propels decentralized infrastructures into mainstream adoption."Incentivized Testnet LaunchThe upcoming Testnet launch will allow users to participate in stress-testing this revolutionary system. Validating and maintaining security standards, while counteracting threats like phishing and network breaches, the testnet will lay the groundwork to seed a global post-quantum cybersecurity DePIN.For Testnet participation, visit https://naorisprotocol.network/For more information, visit https://www.naorisprotocol.com/ Naoris Protocol is available for interviews and technical demonstrations of their groundbreaking DePIN solution for cybersecurity and digital trust.Check out our White PapersStay connected: Twitter | Discord | Telegram | LinkedInContact: Guy DaviesCMO, Naoris ProtocolGuy@Naoris.com Copyright 2024 ACN Newswire via SeaPRwire.com.

HONG KONG, Dec 4, 2024 - (ACN Newswire via SeaPRwire.com) – The 25th Hong Kong Forum drew to a successful close today, facilitating exchange and creating cooperation opportunities among businesses from different regions. Jointly organised by the Hong Kong Trade Development Council (HKTDC) and the Federation of Hong Kong Business Associations Worldwide (FHKBAW), the two-day event attracted more than 320 business leaders from 28 countries and regions, focusing on hot topics such as Hong Kong's business outlook, the development of the Northern Metropolis and youth entrepreneurship, providing participants with in-depth insights into different areas and actively promoting the advantages of Hong Kong's "eight centres".Promoting Hong Kong as a key international business platformGiving the opening remarks on the first day of the event, Margaret Fong, Executive Director of the HKTDC, said: “We have held the Hong Kong Forum for 25 consecutive years. In the late 1990s, when the Asian financial crisis gripped much of the region and the long process of recovery had just begun, we launched this event to demonstrate to the world that, despite the crisis, our city remained a vital international business platform.”She also mentioned the development of the Guangdong-Hong Kong-Macau Greater Bay Area (GBA). “With Hong Kong being the most international city in the GBA and a two-way gateway to Mainland China, our city is a ‘super-connector’ linking the mainland with the world. With our strengths in traditional industries and the strides we are making in newer sectors, Hong Kong is brimming with opportunities. Amid today’s digital and sustainability agendas, the city is accelerating its transition towards a more innovation-driven, digitally competitive and greener future.”Hans Poulis, Chairman of the Federation of Hong Kong Business Associations Worldwide, said: “We had some remarkable sessions lined up this year, including a discussion on the foundation of global competitiveness that emphasised the critical role of the rule of law and international cooperation in maintaining Hong Kong's status as a leading financial hub. We also explored the Northern Metropolis initiative, which aims to position Hong Kong as an international business and innovation hub, highlighting its strategic significance within the Greater Bay Area. We also delved into the efforts of local industries to drive sustainability, showcasing innovative practices that are shaping a greener future for Hong Kong.”John Lee, Chief Executive of the HKSAR, was Guest of Honour at the Hong Kong Forum’s keynote luncheon on the second day of the event (4 December). He said: “Hong Kong is the world's ‘super connector’. Hong Kong has long attracted businesses and investors, thanks to our clear and compelling advantages - from a free and open investment environment and simple and low tax system, to modern infrastructure and logistics networks and the unfettered flow of information, capital, goods and people.”He additionally mentioned: “To build on our strengths, the Hong Kong SAR Government has implemented a wide range of initiatives, over the past two years, promoting economic opportunities. We are pressing ahead with the development of the ‘eight centres’ of excellence, as set out in the 14th Five-Year Plan, as well as the Northern Metropolis, the new engine of Hong Kong's economic future. We've also set up Hong Kong Talent Engage and the Office for Attracting Strategic Enterprises, to boost our strategic value and drive for talent and enterprises.”Focusing on HK’s legal system, the Northern Metropolis and green transformationUpholding the rule of law and maintaining strong international cooperation are essential to the continued success of Hong Kong as a global financial and business hub. In a session titled “The Foundation of Global Competitiveness” on the first morning of the forum, Rimsky Yuen, Senior Counsel and former Secretary for Justice, examined how Hong Kong’s robust legal system, based on the principles of common law and the independence of the judiciary, has been instrumental in establishing the city as an open, transparent and trusted place for business.The latest Policy Address highlighted how Hong Kong is moving forward, with the Northern Metropolis becoming a new engine for the city’s future growth. Vic Yau, Director of the Northern Metropolis Co-ordination Office of the Development Bureau, provided participants with an overview of the key features and strategic significance of the Northern Metropolis initiative, highlighting its potential to strengthen Hong Kong's role as a leading finance-technology "dual engine" within the GBA. The Northern Metropolis will provide a new economic impetus for Hong Kong, underpinned by innovation and technology development that will help the city develop into an international business and innovation hub.Sustainability was also in focus at the forum, with local business leaders sharing their valuable experience in promoting green transformation in different industries and enterprises and providing participants with a comprehensive overview of their sustainability efforts and innovations. The speakers included Adriel Chan, Chair of the Hang Lung Group; Joseph Law, Managing Director of CLP Power; Poman Lo, Vice Chairman and Managing Director of Regal Hotels International; and Heidi Yu Spurrell, Founder & CEO, Future Green.In the morning session on the second day of the forum, a group of young Hong Kong-based entrepreneurs, include Sidhant Gupta, Cofounder of Clear Robotics Limited; Carla Martinesi, CEO & Cofounder of CHOMP; and Christian Secci, CEO & Cofounder of alfred24, discussed their experiences running startups with a focus on innovation and transformation, exploring how innovation drives entrepreneurship and creates fresh ideas, new technologies and different models that can help to transform industries.The forum also announced the latest addition to the FHKBAW, with the Spain-Hong Kong Business Association joining its ranks this year. This signals the continued expansion of the federation and reflects the strong interest European countries have in establishing ties with Hong Kong.Global business representatives visit Hong Kong logistics facilitiesOver the two days of the forum, FHKBAW representatives visited key logistics facilities, including Hong Kong Air Cargo Terminals Limited, Hong Kong International Airport and Cainiao Smart Gateway, to gain a better understanding of the latest developments in Hong Kong's logistics and air cargo industry, and to experience the unique opportunities presented by city’s “eight centres".The Hong Kong Forum is the annual flagship event of the FHKBAW. The federation, founded in 2000, comprises a network of 49 business associations with about 11,000 business executives and professionals from 38 countries and regions as its members.Forum website: https://hkforum.hktdc.com/conference/hkforum/enPhoto download: http://bit.ly/4ilc2AnThe 25th Hong Kong Forum, organised by the Hong Kong Trade Development Council (HKTDC) and the Federation of Hong Kong Business Associations Worldwide (FHKBAW), concluded todayThe two-day event attracted more than 320 business leaders from 28 countries and regionsMargaret Fong, HKTDC Executive Director, said in her opening remarks that with Hong Kong’s strengths in traditional sectors and the strides it is taking in newer sectors and industries, the city is brimming with opportunitiesHans Poulis, Chairman of the Alliance of Hong Kong Business Associations Worldwide, delivered one of the opening speeches on the first day of the forumJohn Lee, Chief Executive of the HKSAR was the Guest of Honour at the Hong Kong Forum’s keynote luncheon on the second day of the event (4 December)The two-day forum featured in-depth discussions on a range of hot topics including sustainability and youth entrepreneurshipMedia enquiriesPlease contact the HKTDC’s Communications and Public Affairs Department:Clayton Lauw Tel: (852) 2584 4472 Email:clayton.y.lauw@hktdc.org HKTDC Media Room: http://mediaroom.hktdc.com About FHKBAWThe Federation of Hong Kong Business Associations Worldwide is a unique network of 49 Hong Kong Business Associations in 38 countries and regions with about 11,000 individual associates. These Hong Kong Business Associations were started by overseas traders, buyers and professionals, who have strong business links to Hong Kong in their respective countries, for the purpose of networking and exchanging of business information and ideas. Each of these Associations has their own individual members who are top business people and SMEs in their home country. They are Hong Kong's closest allies and partners in the world market. With the help of the Hong Kong Trade Development Council (HKTDC), these Associations formed the Federation of Hong Kong Business Associations Worldwide in November 2000. The Federation aims to achieve synergy among the global network of Hong Kong Business Associations. It provides an effective base for member associations to network and exchange information, thereby, generating business opportunities. Website: https://www.hkfederation.org.hk/aboutAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Copyright 2024 ACN Newswire via SeaPRwire.com.

SINGAPORE, Dec 5, 2024 - (ACN Newswire via SeaPRwire.com) - Momomi®, the home product brand, has officially launched in Singapore, bringing a unique collection designed to enhance family living. This exciting entry marks a significant development in the local home products market, where consumers are increasingly seeking high-quality, family-friendly, and stylish home product options. Momomi® aims to meet this growing demand by offering products that bring happiness to families.Momomi®'s core concept revolves around enhancing the joy and well-being of your family through the range of exceptional Momomi® products. Designed with love and care, each item is crafted to elevate the home experience, making every moment with your loved ones truly special.The signature collection, Momomi® Mat, exemplifies this mission with its revolutionary design, suitable for all ages, adding both comfort and aesthetic appeal while fostering a nurturing family environment and enhancing family quality time. It is crafted from premium materials, including super soft top fabric layers, exclusive formula of waterproof PuffySponge™, and an anti-slip backing. This combination ensures superior comfort and practicality for busy families. Additionally, the mat is breathable, making it ideal for a variety of climates and suitable for all seasons. Its easy-to-clean, pet-friendly design makes it a perfect fit for all family members, from infants to seniors.In Singapore's evolving market, consumers are increasingly prioritizing sustainable and ethically produced home furnishings. Momomi® stands out in this competitive landscape with its artisanal craftsmanship and customizable options, setting it apart from other home product brands. The brand collaborates with skilled female artisans, providing them with sustainable income while showcasing their talent globally, underscoring Momomi®'s dedication to ethical production.Momomi® products are available for purchase through their official website,momomi.world, and at the upcoming Mummy Markets Baby Expo, Singapore's largest parenting expo.About Momomi®:Momomi® is a family-focused brand dedicated to enhancing home life with carefully designed products. Each item is crafted to create a joyful and comfortable living environment. The brand's signature Momomi® Mat offers a blend of comfort, style, and practicality, fitting seamlessly into any space. Committed to ethical production, Momomi® works with skilled artisans, providing sustainable income while showcasing their craftsmanship globally-experience how Momomi® transforms everyday moments into lasting family memories.Contact Information:Momomi®Website:momomi.worldEmail: contact@momomi.worldInstagram:@momomi.worldContact InformationGigi NgMarketing Managercontact@momomi.worldSource: Momomi® Copyright 2024 ACN Newswire via SeaPRwire.com.

SAN JOSE, CA, Dec 5, 2024 - (ACN Newswire via SeaPRwire.com) - In an era where 75% of security breaches are attributed to weak authentication, the importance of robust cybersecurity measures has never been greater. Recognizing this critical need, TACACS.net has emerged as the #1 choice for Active Directory (AD) integration, offering unmatched reliability, performance, and security.Authentication is often the weakest link in network security. If a hacker cannot authenticate to a device, they cannot exploit it. TACACS.net addresses this vulnerability by delivering a solution built to meet the needs of modern organizations, ensuring fast, secure, and seamless integration with existing infrastructure.Why TACACS.net Stands OutMost organizations rely on Active Directory to manage users, but competing solutions depend on middleware-complex intermediaries that often fail, usually at the worst possible time. TACACS.net is the only TACACS+ server built to run directly on Domain Controllers, eliminating middleware and ensuring native communication with your domain. This approach translates to faster, more stable, and inherently secure performance.Key Features of TACACS.netSeamless Active Directory Integration: Extends AD functionality to network devices such as routers, switches, firewalls, Wi-Fi controllers, and load balancers, using existing Users and Groups.Advanced Authorization Policies: Enables granular control over network access based on AD group memberships.Simplified Single Sign-On (SSO): Reduces administrative overhead while enhancing user experience.Included Multi-Factor Authentication (MFA): Provides robust MFA capabilities at no extra cost, improving authentication security.Transparent to Users: Your Users authenticate directly to network devices like they already do, without going through an intermediary jump server or proxy, and they can use their existing AD credentials.Unparalleled Technical Support: SLA-backed support is available via phone and email during business hours, with 24/7/365 support options for mission-critical environments.Built for Enterprise and ComplianceTACACS+ is a recognized Best Practice for security and is either required or strongly recommended to meet compliance requirements for many industries. Furthermore, top enterprise manufacturers already support TACACS+, so your network devices likely just need it enabled-making it a simple and cost effective, yet transformative upgrade. TACACS.net is the fastest, easiest, and most cost effective way to dramatically increase your security posture.A Decade of ExcellenceWith over a decade of proven reliability, TACACS.net has gained the trust of customers through outstanding service and support, responsible growth, and a steadfast commitment to dependability. Demonstrating exceptional scalability and adaptability, the company supports diverse deployment requirements, including federal government and military, defense, aerospace, large enterprise, banking institutions, and multi-continent WANs. This proven longevity and versatility underscore its unwavering strength and reliability in the dynamic and ever-evolving landscape of cybersecurity.About TACACS.netTACACS.net is a leading provider of TACACS+ server solutions, offering enterprise-grade authentication, authorization, and accounting (AAA) with native Active Directory integration. With built-in Multi-Factor Authentication (MFA) and advanced support options, TACACS.net is designed to meet the demands of modern networks, ensuring secure and reliable access management for organizations worldwide.For More InformationTo learn more about how TACACS.net can enhance your network security, visit www.tacacs.net or contact the sales team click here: Sales Information Request or sales@tacacs.netSecure Your Network Today. Choose TACACS.net.SOURCE: TACACS.net Copyright 2024 ACN Newswire via SeaPRwire.com.

BAD HOMBURG, GERMANY, Dec 5, 2024 - (ACN Newswire via SeaPRwire.com) - Maxon, maker of powerful, approachable software solutions for content creators working in 2D and 3D design, motion graphics, visual effects, and more, today released updates across its Maxon One product suite, with new features in Cinema 4D, Redshift, ZBrush and ZBrush for iPad, and Red Giant. The release fulfills artists' holiday wishlists with new capabilities that enhance everyday workflows and improve quality of life for artists, animators, VFX professionals, and studios.Image courtesy of Patrick 4DWhether it's crafting unique models using brand new Cinema 4D Booleans that give cookie-cutter a whole new meaning or bringing a dazzling snowfall to life with Cinema 4D Particles, Maxon One makes it all possible. GoZ in ZBrush for iPad now makes it even easier to transfer creations from the comfort of your couch to the power of your PC or Mac, where the magic of ZBrush, Cinema 4D, Red Giant and Redshift bring those visions to life."From broadcast and film to branding, character creation to world-building, there is no corner of art and design that Maxon One tools do not touch, and with every new release, we aim to make the lives of creative professionals that much easier and more enjoyable - and what better time to bring the joy than the holidays?" said Philip Losch, CPTO of Maxon. "This update delivers improvements based on community input, from the powerful new Boolean workflows in Cinema 4D to cross platform workflows with ZBrush for iPad. Each enhancement inspires innovation across diverse creative fields that permeate through our everyday lives, whether that's on the screen, in the creation of consumer goods or architectural design, and even medical animation of world-changing ideas."Baking Holiday Magic With Patrick 4D3D artist and "Digital Chef" Patrick 4D, who specializes in digital photorealism for food and products, is teaming up with Maxon to bake up some digital goodies for the holiday season: a collection of gingerbread cookies crafted in ZBrush. Available now in the trial or full version of ZBrush, artists can make the cookies their own with tasty decorations and world building. To join in on the fun, share your creations with the Maxon community by tagging @maxonvfx on Instagram.Models That are Anything but Cookie-Cutter with Cinema 4DCinema 4D 2025.1 introduces a completely new Boolean generator that allows artists to easily create complex shapes from animated elements, streamlining the modeling process through intuitive shape addition and subtraction. This new algorithm is faster and more robust, enabling users to work with complex geometry while maintaining high frame rates, even with intricate animated booleans. The flexible user interface allows for the combination of multiple inputs and operations into a single boolean object, a significant upgrade from the previous limitation of just two inputs.In Cinema 4D, precise control over particle behavior is now possible with custom properties and the Particle Node Modifier, part of the growing GPU-accelerated Unified Simulation toolset, offering greater flexibility and creativity. Existing customers will appreciate quality-of-life improvements in Cinema 4D, including enhanced USD import/export and improvements to XRef performance and reliability for seamless collaboration. Interactive tutorials in the Learning Panel combine video guidance and UI highlights to simplify concepts and accelerate the learning process.Redshift Renders Really Fly With an AI Boost and Improved VisualizationRedshift combined with Cinema 4D and ZBrush are the ultimate building blocks for character and product design and architectural visualization, empowering creative professionals to craft breathtaking designs and models that transport clients to new dimensions. Redshift 2025.2 brings continued improvements to Toon rendering, even faster renders in ZBrush and Cinema 4D, and support for fully three-dimensional contours.Tightening of the Substance integrations gives users a fantastic workflow across Adobe and Maxon solutions (available as a bundle). Redshift Random Material Switch makes it easy to vary materials across MoGraph clones and other objects, while improved cross-platform AI-based denoising enables faster and more efficient renders.Creativity Unwrapped with ZBrush (for iPad)The cross-platform compatibility for ZBrush creations continues to see enhancements, with the ability to transfer with just a few clicks from iPad to desktop, where artists can refine, add animation and materials, and render. The complete workflow from concept to render starts the moment creativity strikes thanks to GoZ technology, and for the first time, artists can exchange creations bidirectionally between ZBrush for iPad and Cinema 4D. GoZ has also simplified the process of sending ZBrush sculpts to the 2025 versions of Maya and 3DSMAX.ZBrush desktop also now includes faster Redshift rendering, with denoising and separate AOV passes for shadows, reflections and more to more easily composite in Photoshop. The Anchor Brush in ZBrush for Desktop now has a new Bend mode, allowing users to easily pose characters using two anchor points.Additional updates to ZBrush for iPad, released in November, include UV and texture mapping, surface noise, localization, and improved support for Apple Pencil Pro. ZBrush for iPad includes nearly all the power of the full desktop application, and Maxon continues to close the gap with popular features to customize surfacing.Feeling Festive and On-Trend with Red Giant and Maxon StudioMaxon One's powerhouse for adding personal or branded flair to any project, Red Giant 2025.2 includes updates in Maxon Studio and Universe that make it easy for content creators to level up their videos with on-trend effects, transitions and motion templates. 2D Motion Designers and Compositors can get started easily with the help of Maxon Studio, an After Effects templating toolkit that offers hundreds of customizable graphics and effects, including a set of meticulously crafted Film Title templates. And, always on trend, Universe and Red Giant subscribers can now make use of six new Pixel Dither effects for effortless pixel art creation, using advanced dithering effects that capture the essence of retro gaming and animation.About MaxonMaxon makes powerful, yet approachable software solutions for content creators working in 2D and 3D design, motion graphics, visual effects and visualization. Maxon's innovative product portfolio helps artists supercharge their creative workflows. Our product lines include the award-winning Cinema 4D suite of 3D modeling, simulation and animation technology; the creativity-on-the-go Forger mobile sculpting app; the diverse Red Giant lineup of revolutionary editing, motion design and filmmaking tools; the leading-edge, blazingly fast Redshift renderer; and ZBrush, the industry-standard digital sculpting and painting solution.Press ContactMegan FasyGrithaus Agency(e) megan@grithaus.agency(p) +1 (617) 480-3674SOURCE: Maxon Computers Copyright 2024 ACN Newswire via SeaPRwire.com.

SINGAPORE, Dec 4, 2024 - (ACN Newswire via SeaPRwire.com) - How much sugar does a Singaporean typically take in a day? In a recent speech by Health Minister Mr. Ong Ye Kung, Singapore is too sweet. While the average daily sugar intake of Singaporeans has fallen from 60g in 2018 to 56g in 2022, this number still works out to about 11 teaspoons of daily sugar consumption, about 10% higher than the ideal intake of less than 50g.Amid an ageing population, the younger generation in Singapore is also increasingly affected by this chronic condition, highlighting a growing national health concern related to sugar consumption.Sugar, a common mis-solution to anxiety, often provides a sense of fleeting comfort. The instant boost in dopamine from sugar can create a cycle of dependency, giving temporary relief from stress or anxiety but contributing to harmful physical effects, such as inflammation, weight gain, and insulin resistance.The overconsumption of sugar, combined with sedentary lifestyles and other unhealthy dietary habits have contributed to diabetes becoming a major global health crisis today – Alarmingly, diabetes rates are rising among the younger generation, including both teenagers and young adults, contributing to nearly half a million cases in Singapore. Astonishingly, 40% of Singaporeans remain unaware of their pre-diabetic status, an often silent condition that could lead to type 2 diabetes.Diabetes is a chronic condition that if left unmanaged, can lead to serious health complications, including an increased risk of cardiovascular disease, kidney failure, nerve damage or even vision loss. However, type 2 diabetes can be prevented through proactive lifestyle changes, including healthy eating, regular physical activity, so as to maintain optimal blood sugar levels.In line with World Diabetes Day on 14 November, LAC (pronounced as L-A-C) is dedicated to highlight the importance of taking preventative measures against diabetes. By incorporating supplements that support blood sugar regulation and reduce carbohydrate absorption, along with a healthy diet and increased physical activity, individuals can maintain their glucose levels and maintain their metabolic health.LAC GlucoX is designed to support healthy glucose levels. Formulated with bitter melon and Fibersol-2, Banaba leaf, Gymnema, Chromium and Brown Seaweed, GlucoX helps slow down carbohydrate absorption and optimises glucose utilisation, supporting individuals in managing their blood sugar levels effectively.LAC Bitter Melon Formula, is formulated with Momordica Charantia Polysaccharide (MCP), a key compound from bitter melon known for its ability to support healthy blood glucose levels. It enhances the body’s ability to regulate insulin production and supports the overall metabolic health of individuals. Copyright 2024 ACN Newswire via SeaPRwire.com.

SAN FRANCISCO, CA & MUMBAI, Dec 2, 2024 - (ACN Newswire via SeaPRwire.com) - CleverTap, the all-in-one engagement platform, has released its market research report on “The State of App and Web User Experience Optimization”. The report sheds light on how digital-first brands are leveraging experimentation and personalization on their apps and websites to drive customer engagement and business growth. It also highlights roadblocks faced by marketers and product managers while experimenting with the UI, workflows, and functionality across apps and websites.For a thorough understanding of the current landscape, this report draws insights from a diverse group of respondents – with data gathered through structured surveys and in-depth interviews – representing organizations with over two million customers across 50+ countries. This includes VPs, CMOs, and product managers ranging from startups to large enterprises across various industries. – Together, they offer valuable insights into how businesses optimize app and web experiences to drive customer engagement and business growth.While 95% of surveyed product managers and 88% of marketers believe that the right user experience is essential for driving customer engagement and retention — many report significant challenges to effectively experimenting with app and web user experiences. Despite recognizing its importance, they reported difficulties such as limited resources, data gaps, and technical constraints that hinder their ability to innovate and deliver impactful user experiences. Other notable findings from the report include -81.9% of product managers rarely experiment with their app and web experiences before making changes to them. The top challenges quoted include lack of resources (46%), inadequate data and analytics (31%), and technical issues (19%)54% of product managers are unable to support marketers in experimenting with onboarding flows, banner placement, homepage content and other similar app and web experiences.81% of marketers believe it would make a significant impact if they could independently experiment with multiple variations of web and app experiences within a no-code framework provided by their product management function.Commenting on the report, Jacob Joseph, Vice President - Data Science, CleverTap said, “With consumer expectations constantly rising, brands need to go beyond perfecting their channel strategies and also focus on enhancing the in-app and web experiences to drive results from their marketing efforts. Since all channels ultimately lead users to the app or website, an unsatisfactory experience there can render all your efforts ineffective and become a missed opportunity. Personalization and experimentation on apps and websites are critical to reducing churn and driving growth, yet resource constraints and data gaps hinder marketers and product managers. We are committed to helping businesses navigate these challenges with CleverTap’s Product Experiences, which offers effortless ways to personalize and experiment with app and web experiences driving stronger engagement and lasting brand loyalty."For more information and insights download the report here. About CleverTapCleverTap is the leading all-in-one customer engagement platform that helps brands unlock limitless customer lifetime value. CleverTap is trusted by over 2000 brands like Decathlon, Domino’s, Levis, Jio, Emirates NBD, Puma, Croma (A Tata Enterprise), Swiggy, SonyLIV, Axis Bank, AirAsia, TD Bank, Ooredoo, and Tesco to help build personalized experiences for all their customers. The platform is powered by TesseractDB™ – the world’s first purpose-built database for customer engagement, offering speed and cost efficiency at scale.Backed by top-tier investors such as Accel, Peak XV Partners, Tiger Global, CDPQ and 360 One, the company is headquartered in San Francisco, with presence across Seattle, London, São Paulo, Bogota, Mexico, Amsterdam, Sofia, Dubai, Mumbai, Bangalore, Singapore, Vietnam, and Jakarta.For more information, visit clevertap.com or follow us on:LinkedIn: https://www.linkedin.com/company/clevertap/ X: https://twitter.com/CleverTap Forward-Looking StatementsSome of the statements in this press release may represent CleverTap's belief in connection with future events and may be forward-looking statements, or statements of future expectations based on currently available information. CleverTap cautions that such statements are naturally subject to risks and uncertainties that could result in the actual outcome being absolutely different from the results anticipated by the statements mentioned in the press release.Factors such as the development of general economic conditions affecting our business, future market conditions, our ability to maintain cost advantages, uncertainty with respect to earnings, corporate actions, client concentration, reduced demand, liability or damages in our service contracts, unusual catastrophic loss events, war, political instability, changes in government policies or laws, legal restrictions impacting our business, impact of pandemic, epidemic, any natural calamity and other factors that are naturally beyond our control, changes in the capital markets and other circumstances may cause the actual events or results to be materially different, from those anticipated by such statements. CleverTap does not make any representation or warranty, express or implied, as to the accuracy, completeness, or updated or revised status of such statements. Therefore, in no case whatsoever will CleverTap and its affiliate companies be liable to anyone for any decision made or action taken in conjunction.For more information:SONY SHETTYDirector, Communications, CleverTap+91 9820900036sony@clevertap.comASHMIT CHAUDHARYAssociate Consultant, Archetype+91 8850752121ashmit.chaudhary@archetype.co Copyright 2024 ACN Newswire via SeaPRwire.com.

- Patients in the low-dose cohort who have completed 36 weeks of treatment, 9 out of 11 (81.8%) achieved overall clinical remission and 10 out of 11 (91%) achieved immunological complete remission.- In the high dose cohort, 6 out of 7 (85.7%) patients achieved overall clinical remission and all patients achieved immunological complete remission by week 24.- EVER001 was generally safe and well tolerated. No clinically significant adverse events typically associated with earlier-generation BTK inhibitors, such as bleeding, arrhythmia, severe infection, leukopenia, thrombocytopenia, or severe liver function impairment, were reported.SHANGHAI, Dec 4, 2024 - (ACN Newswire via SeaPRwire.com) - Everest Medicines (HKEX 1952.HK,“Everest”, or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced positive results in the ongoing Phase 1b/2a clinical trial for the treatment of primary membranous nephropathy (pMN) with EVER001 (previously known as XNW1011), a next-generation covalent reversible Bruton's tyrosine kinase (BTK) inhibitor. In an analysis of the data available as of September 13th, 2024, results from the Phase 1b/2a clinical trial showed that for patients in the low-dose cohort who have completed 36 weeks of treatment, 9 out of 11 (81.8%) achieved overall clinical remission1 and 10 out of 11 (91%) achieved immunological complete remission (ICR)2. In the high dose cohort, 6 out of 7 (85.7%) patients achieved overall clinical remission and all patients achieved ICR by week 24.EVER001 is a covalent reversible BTK inhibitor with potentially best-in-class characteristics for the treatment of autoimmune renal diseases. Compared to covalent irreversible BTK inhibitors, EVER001 offers improved selectivity while maintaining high potency, thereby potentially avoiding many of the side effects associated with earlier-generation BTK inhibitors. Everest Medicines holds global rights to EVER001 for the treatment of renal diseases.The Phase 1b/2a clinical trial of EVER001 for the treatment of pMN is an ongoing trial conducted in China. A total of 31 patients with biopsy-proven pMN who tested positive for anti-PLA2R autoantibodies were enrolled into two cohorts. The total treatment duration was 36 weeks. Based on the patient data collected by September 13th, 2024, in the low-dose cohort, the geometric least squares mean 24-hour proteinuria decreased by 78.3% at week 36 compared to baseline, while the high-dose cohort achieved a 73.8% reduction by week 24. EVER001 treatment induced greater than 90% reductions in anti-PLA2R antibody as early as week 24 in the low-dose cohort and week 12 in the high-dose cohort. EVER001 was generally safe and well tolerated. No clinically significant adverse events typically associated with earlier-generation BTK inhibitors, such as bleeding, arrhythmia, severe infection, leukopenia, thrombocytopenia, or severe liver function impairment, were reported."We are excited to see the encouraging results in this preliminary analysis of our Phase 1b/2a clinical proof-of-concept trial of EVER001. This demonstrates the potential of EVER001 as a next-generation BTK inhibitor for the treatment of various autoimmune renal diseases, including pMN. "Rogers Yongqing Luo, Chief Executive Officer of Everest Medicines, said："This data release marks the first time Everest Medicines has disclosed results from its global pipeline. We look forward to completing this trial and sharing detailed data in future conferences and publications. Moving forward, we will continue to drive the global clinical development of EVER001, to meet patients' urgent clinical needs.”Membranous nephropathy is a common pathological type of nephrotic syndrome in adults, and its prevalence in China has been increasing, ranking second only to IgA nephropathy3. There are about 2 million patients with pMN in China, with an estimated 80,000 to 100,000 patients in the United States, 80,000 in Europe, and 40,000 in Japan. There are no approved drugs for this indication worldwide. The current treatment goal is to improve remission rates, reduce high relapse rates, and minimize the risk of chronic toxicity caused by currently available treatments. More than one-third of pMN patients still progress to end-stage renal disease under current standards of care.This Phase 1b/2a clinical trial was approved by the Center for Drug Evaluation of the National Medical Products Administration in September 2022 to evaluate the safety, efficacy, pharmacokinetics, and pharmacodynamics of EVER001 in Chinese patients with glomerular diseases characterized by proteinuria. The previously published results of a Phase 1 study conducted in healthy Chinese and Australian subjects conducted by SinoMab BioScience indicate that EVER001 has high selectivity, excellent pharmacokinetic properties, a good safety profile, and strong target binding.About EVER001EVER001 (previously known as XNW1011) is a next-generation covalent reversible Bruton's tyrosine kinase (BTK) inhibitor in development globally for the treatment of renal diseases. BTK is an essential component of the B-cell receptor signaling pathways that regulate the survival, activation, proliferation, and differentiation of B lymphocytes. Targeting BTK with small molecule inhibitors has been demonstrated to be an effective treatment option for B-cell lymphomas and autoimmune diseases. Based in part on results from a completed phase 1 trial with healthy subjects conducted by SinoMab in China, EVER001 exhibited high selectivity, excellent pharmacokinetics properties, strong target binding and a safety profile that supports continued clinical development.Under an exclusive licensing agreement with Sinovent Pharmaceuticals and SinoMab BioScience, Everest owns global rights to develop, produce and commercialize EVER001 for the treatment of renal diseases.Investor Calls InformationEverest Medicines will hold investor calls on the data results from EVER001 Phase 1b/2a clinical study in primary membranous nephropathy. EVER001 is a next-generation covalent reversible Bruton’s tyrosine kinase (BTK) inhibitor, and Everest owns the global rights to develop EVER001 for the treatment of renal diseases.The English session of the conference call will be held at 9:00 AM on Dec. 4, 2024, Beijing Time (8:00 PM U.S. Eastern Time on Dec. 3, 2024) and the Mandarin session of the conference call will be held at 10:30 AM Beijing Time on the same day (9:30 PM U.S. Eastern Time on Dec. 3, 2024).The conference calls can be accessed by the following links:For English Session:Time: 9:00 AM Beijing Time, Wednesday, Dec. 4, 2024 (8:00 PM U.S. Eastern Time on Dec. 3, 2024)Pre-Registration Link: https://www.acecamptech.com/eventDetail/60510700Webcast Link:https://www.acecamptech.com/meeting_live/70512679/774680?event_id=60510700Alternatively, participants may dial in to the conference call using below dial-in information:United States: +1-646-2543594 (EN)Chinese Mainland: +86-10-58084166 (EN), +86-10-58084199 (CN)Hong Kong, China: +852-30051313 (EN), +852-30051355 (CN)United Kingdom: +44-12-1368-0466 (EN)International: +1-866-6363243 (EN)Password: 842080For Mandarin Session:Time: 10:30 AM Beijing Time, Wednesday, Dec. 4, 2024 (9:30 PM U.S. Eastern Time on Dec. 3, 2024)Webcast Link: https://s.comein.cn/n3arj55sAlternatively, participants may dial into the conference call using below dial-in information:United States: +1-646-3578788, +1-408-7093255Chinese Mainland: 400-969-8928, 400-806-3263Hong Kong, China: +852-301-83602Taiwan, China: +886-226563394, +886-277417882Singapore: +65-64075649, +65-66220840United Kingdom: +44-2070970018 International: +86-2362737123Password: 377570The replay of English session will be available shortly after the call and can be accessed by visiting the Company’s website at http://www.everestmedicines.com.About Everest MedicinesEverest Medicines is a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing transformative pharmaceutical products and vaccines that address critical unmet medical needs for patients in Asian markets. The management team of Everest Medicines has deep expertise and an extensive track record from both leading global pharmaceutical companies and local Chinese pharmaceutical companies in high-quality discovery, clinical development, regulatory affairs, CMC, business development and operations. Everest Medicines has built a portfolio of potentially global first-in-class or best-in-class molecules in the company’s core therapeutic areas of renal diseases, infectious diseases and autoimmune disorders. For more information, please visit its website at www.everestmedicines.com.Forward-Looking Statements:This news release may make statements that constitute forward-looking statements, including descriptions regarding the intent, belief or current expectations of the Company or its officers with respect to the business operations and financial condition of the Company, which can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “confident” and similar statements. Such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, or other factors, some of which are beyond the control of the Company and are unforeseeable. Therefore, the actual results may differ from those in the forward-looking statements as a result of various factors and assumptions, such as future changes and developments in our business, competitive environment, political, economic, legal and social conditions. The Company or any of its affiliates, directors, officers, advisors or representatives has no obligation and does not undertake to revise forward-looking statements to reflect new information, future events or circumstances after the date of this news release, except as required by law.References:1.Overall clinical remission (complete remission or partial remission): 24h proteinuria complete remission (CR): 24h proteinuria < 0.3g/24 h; 24h proteinuria partial remission (PR): 24h proteinuria < 3.5g/24h, but ≥0.3g/24 h, and reduction > 50%, regardless of eGFR or the serum albumin level from baseline.2. Immunological complete remission (ICR): anti-PLA2R titer < 20RU/ml (negative).3. Expert consensus on the application of rituximab in the treatment of membranous nephropathy, Chin J Intern Med, March 2022, Vol. 61, No. 3. Copyright 2024 ACN Newswire via SeaPRwire.com.

SINGAPORE, Dec 4, 2024 - (ACN Newswire via SeaPRwire.com) - OKX, the leading cryptocurrency exchange, has partnered with DeAgentAI, the first AI-driven feedback incentive protocol in Web3, to launch an exclusive airdrop campaign. Starting December 3rd, users can complete simple tasks on OKX Wallet to win a share of $50,000 worth of DA tokens.Click here to join the campaign: https://www.okx.com/web3/giveawayParticipating in the DeAgentAI and OKX Wallet airdrop is easy. Download the OKX Wallet, follow DeAgentAI social media networks, and complete a few simple tasks such as sharing campaign posts, and you can claim your rewards. The campaign runs from December 3rd for two weeks-don't miss out!This collaboration brings users unparalleled opportunities to explore advanced AI technology while enjoying the benefits of a secure and user-friendly wallet. With rewards of $50,000 worth of DA tokens, the initiative encourages users to explore Web3 in an innovative and incentivized environment. DeAgentAI and OKX Wallet aim to foster adoption and empower users in the rapidly evolving crypto space.About DeAgentAIDeAgentAI is a trailblazer in Web3 technology, introducing the first AI feedback mechanism incentive protocol that achieves "proof of insight" by integrating user feedback into the model training process. Its flagship product, AlphaX, combines advanced MOE and Transformer architectures to predict BTC and ETH price trends with over 80% accuracy.What is OKX's Web3 Wallet?OKX Wallet complements this innovation with its secure and user-friendly interface tailored for decentralized finance (DeFi) and Web3 applications. As a leading wallet in the crypto space, OKX Wallet enables seamless integration with platforms like DeAgentAI, empowering users to engage in token giveaways, explore cutting-edge AI tools, and participate in the rapidly growing Web3 ecosystem.Contact InformationYves-Alexandre d'OuradouFounderdeagent.ai@gmail.com(001) 2024989991Source: DeAgentAI Copyright 2024 ACN Newswire via SeaPRwire.com.

SAN DIEGO, CA, Dec 4, 2024 - (ACN Newswire via SeaPRwire.com) - The Japan Maritime Self-Defense Force (JMSDF) has selected the General Atomics Aeronautical Systems, Inc. (GA-ASI) SeaGuardian® Remotely Piloted Aircraft (RPA) systems for its Long Endurance Unmanned Aerial Vehicle program. This follows JMSDF use of SeaGuardian since May 2023 as part of its Medium-Altitude, Long Endurance (MALE) RPA System Trial Operations Project.SeaGuardian has been used by JMSDF to conduct various tests including whether unmanned aircraft can supplant some of the missions currently accomplished with manned aircraft. SeaGuardian is a MALE RPA system that can fly for 24 hours or more, depending on the configuration.GA-ASI has strengthened its Maritime Wide Area Surveillance (MWAS) for Japan with Optix+, which gathers information from the SeaGuardian sensors, as well as other data sources, displaying the full picture of surveillance information for its operator. This functionality makes it easy to task and direct its Intelligence, Surveillance and Reconnaissance (ISR) information in real time. GA-ASI's Optix+ software suite rapidly correlates and exploits collected data into an easily shared common operational picture. Having multi-source correlated data enables automatic detection of anomalous behaviors over waters.SeaGuardian features two multi-mode maritime surface-search radars with an Inverse Synthetic Aperture Radar (ISAR) imaging mode, an Automatic Identification System (AIS) receiver, and a High-Definition - Full-Motion Video sensor equipped with optical and infrared cameras as well as electronic intelligence receivers. This sensor suite enables real-time detection and identification of surface vessels over thousands of square nautical miles and provides automatic tracking of maritime targets and correlation of AIS transmitters with radar and electronic intelligence tracks.About GA-ASIGeneral Atomics Aeronautical Systems, Inc. (GA-ASI), an affiliate of General Atomics, is a leading designer and manufacturer of proven, reliable RPA systems, radars, and electro-optic and related mission systems, including the Predator® RPA series and the Lynx® Multi-mode Radar. With more than eight million flight hours, GA-ASI provides long-endurance, mission-capable aircraft with integrated sensor and data link systems required to deliver persistent situational awareness. The company also produces a variety of sensor control/image analysis software, offers pilot training and support services, and develops meta-material antennas.For more information, visit www.ga-asi.com .Avenger, Lynx, Predator, Reaper, SeaGuardian, and SkyGuardian are registered trademarks of General Atomics Aeronautical Systems, Inc.Contact InformationGA-ASI Media Relationsasi-mediarelations@ga-asi.comSource: General Atomics Aeronautical Systems, Inc. Copyright 2024 ACN Newswire via SeaPRwire.com.

Vancouver, British Columbia--(ACN Newswire via SeaPRwire.com - December 3, 2024) - Military Metals Corp. (CSE: MILI) (OTCQB: MILIF) (FSE: QN90) (the "Company" or "MILI") a leading North American exploration company focused on critical minerals, acknowledges today's announcement by China banning exports of gallium, germanium, and antimony to the United States. This move underscores the urgent need for Western nations to secure reliable long-term sources of these essential materials.Antimony, a critical component in military applications, energy storage, and advanced manufacturing, is now at the forefront of the global supply chain crisis. China's ban, coupled with existing restrictions that came into effect September 15, 2024, has already sent antimony prices soaring by over 228% this year(1). The Western world faces mounting pressure to address its reliance on China for strategic resources critical to national defense and technological innovation. This ban comes at a time when defense sector inventories are at already concerningly low levels.(2)Military Metals recent antimony mineral project acquisitions in Slovakia, Nova Scotia, and Nevada provide shareholders with a pure antimony play with a diverse portfolio in top jurisdictions."This announcement from China reinforces the importance of Military Metals' mission to secure a sustainable, independent future supply chain for critical minerals," said Scott Eldridge, CEO of Military Metals Corp. "The West can no longer afford to rely on adversarial nations for resources essential to our security and economic stability. We are taking proactive steps to meet this growing demand with future domestic and allied sources of antimony."As geopolitical tensions escalate and the trade war intensifies, Military Metals will continue to prioritize the development of critical mineral resources and work closely with governments and industry partners to ensure the West remains resilient and self-sufficient.About Military Metals Corp. The Company is a British Columbia-based mineral exploration company that is primarily engaged in the acquisition, exploration and development of mineral properties with a focus on antimony.ON BEHALF OF THE BOARD of DIRECTORSFor more information, please contact:Scott EldridgeCEO and Directorscott@militarymetalscorp.comFor enquiries, please call 604-722-5381 or 604-537-7556This news release contains "forward-looking information". Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates", or "believes" or variations (including negative variations) of such words and phrases, or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward-looking information in this news release include exploration activities, and assumptions related to the continuation of the global demand for antimony. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this news release. These include, geopolitical developments related to the supply of antimony, the continued use of antimony and availability of alternatives, availability of capital and labour in respect of the properties that are the subjects of this news release, the results of any future exploration activities, which cannot be guaranteed, and such other factors as may impact both and any future activities in respect of the properties.. Additional risk factors can also be found in the Company's public filings under the Company's SEDAR+ profile at www.sedarplus.ca. Forward-looking statements contained herein are made as of the date of this news release and the Company disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events or results or otherwise. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. The Company undertakes no obligation to update forward looking statements if circumstances, management's estimates or opinions should change, except as required by securities legislation. Accordingly, the reader is cautioned not to place undue reliance on forward-looking statements.The Canadian Securities Exchange has neither approved nor disapproved the information contained herein and does not accept responsibility for the adequacy or accuracy of this news release.(1)Reuters; China bans export of critical minerals to US as trade tensions escalate; By Amy Lv and Tony Munroe; December 3, 2024(2)Heritage Foundation: commentary/It’s Past Time to Re-Supply Our Munitions-Depleted U.S. Navy by Jim Fein; June 17, 2024To view the source version of this press release, please visit https://www.newsfilecorp.com/release/232325 Copyright 2024 ACN Newswire via SeaPRwire.com.

TSUKUBA, Japan, Dec 2, 2024 - (ACN Newswire via SeaPRwire.com) - Polymers, such as plastics, are essential in many aspects of life and industry, from packaging and cars to medical devices and optic fibres. Their value comes from diverse properties that are largely determined by their monomers – the single chemical units – that make up a polymer. Unfortunately, it can be challenging to control the chemical behaviour of monomers during manufacture to achieve a desired outcome.The flow synthesis reactor with two bottles containing a monomer, initiator and solvent mixed using a micromixer. The synthesis is controlled with AI-based design of experimental conditions such as the temperature and a flow rate. Now, a team of researchers led by Professor Mikiya Fujii of the Nara Institute of Science and Technology in Japan have used machine learning to mathematically model the polymerization process and reduce the need for time-consuming and expensive experimentation. Their results have been published in the journal Science and Technology of Advanced Materials: Methods.Machine learning algorithms need data, so the researchers designed a polymerization process that would quickly and efficiently generate experimental data to feed into the mathematical model. The target molecule was a styrene-methyl methacrylate co-polymer, which was made by mixing styrene and methyl methacrylate monomers, both already dissolved in a solvent with an added initiator substance, then heating them in a water bath.The team also used a method called flow synthesis, in which the two monomer solutions are mixed and heated in a constant flow. This allows for better mixing, more efficient heating, and more precise control of heating time and flow rate, which makes it ideal for use with machine learning.The modelling evaluated the effect of five key variables in the polymerization process: the concentration of the initiator, the ratio of solvent to monomer, the proportion of styrene, the temperature of the reaction, and the time spent in the water bath. The goal was to have an end product with as close to 50% styrene as possible.Once enough experimental data was available, the machine learning process took only five cycles of calculation to achieve the ideal proportion of styrene to methyl methacrylate. The results showed that the key was a lower temperature and longer time in the water bath, as well as lowering the relative concentration of the monomer in the solvent. The researchers were surprised to discover that the solvent concentration was just as important as the proportion of monomers going into the mix.“Our results demonstrate that machine learning not only can explicitly reveal what humans may have implicitly taken for granted but can also provide new insights that weren’t recognized before,” Professor Mikiya Fujii says. “The use of machine learning in chemistry could open the door for smarter, greener manufacturing processes with reduced waste and energy consumption.”Further informationMikiya FujiiNara Institute of Science and TechnologyEmail: fujii.mikiya@ms.naist.jp Paper: https://doi.org/10.1080/27660400.2024.2425178About Science and Technology of Advanced Materials: Methods (STAM-M)STAM Methods is an open access sister journal of Science and Technology of Advanced Materials (STAM), and focuses on emergent methods and tools for improving and/or accelerating materials developments, such as methodology, apparatus, instrumentation, modeling, high-through put data collection, materials/process informatics, databases, and programming. https://www.tandfonline.com/STAM-M Dr Yasufumi NakamichiSTAM Publishing DirectorEmail: NAKAMICHI.Yasufumi@nims.go.jp Press release distributed by Asia Research News for Science and Technology of Advanced Materials. Copyright 2024 ACN Newswire via SeaPRwire.com.

SHENZHEN, CHINA, Dec 2, 2024 - (ACN Newswire via SeaPRwire.com) - China Medical System Holdings Limited (the “Company”, together with its subsidiaries, the “Group” or “CMS”) is pleased to announce that on 2 December 2024, the Group through a wholly-owned subsidiary of the Company entered into an Exclusive Commercialization Agreement (the “Agreement”) with Atom Therapeutics Co., Ltd (hereinafter referred to as “Atom Therapeutics”, formerly named as “Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.”) of class 1 innovative drug ABP-671 for the treatment of gout and hyperuricemia (the “Product”). In accordance with the Agreement, the Group is entitled to an exclusive commercialization right of the Product in Mainland China, Hong Kong Special Administrative Region and Macao Special Administrative Region. The term of cooperation commences on the effective date of the Agreement and extends for ten years from the date the Product is first approved for market launch in Mainland China (the "Authorization Term"). Upon the expiration of the Authorization Term, it may be automatically renewed for an additional ten years, subject to specific conditions stipulated in the Agreement.ABP-671 is a class 1 innovative chemotherapeutic drug for the treatment of gout and hyperuricemia, currently in Phase 2b/3 clinical trials for gout in China and overseas. The Product reduces renal re-absorption of uric acid by inhibiting Urate Anion Transporter 1 (URAT1). The results of two completed phase 2 clinical trials demonstrated favorable efficacy and safety profiles across multiple dose groups (ranging from 1 mg to 12 mg) of ABP-671. The 2 mg once-daily dosage of the Product was proved to be as effective as, or even better than, benzbromarone or febuxostat (maximum dosage of 80mg). The reduction in uric acid levels was sustained throughout the 24-hour period, with no significant safety concerns identified. This product is anticipated to offer more effective and safer treatment alternatives for patients suffering from gout and hyperuricemia[1]. Multiple patents in regard to substance and use of the ABP-671 have been granted in China.Hyperuricemia is defined as a fasting blood uric acid level exceeding 420μmol/L (7.0 mg/dL) in adults on a normal purine diet on two separate days. The deposition of urate crystals in hyperuricemia patient results in arthritis, medically termed gout. Hyperuricemia and gout can cause acute and chronic inflammatory injury in articular cartilage, bone, kidney and vascular wall, which can lead to multiple organ damage of the heart, brain and kidney, etc. The data presented in the White Paper on Hyperuric Acid and Gout Trends in China (2021) indicates that, the incidence rate of hyperuricemia is 13.3%, with approximately 177 million hyperuricemia patients and the incidence rate of gout is 1.1% in general, with about 14.66 million gout patients in China. Frost & Sullivan indicates that, the number of people with hyperuricemia and gout in China will continue to increase in the future, reaching 240 million and 52.2 million respectively by 2030. Currently, the commonly used uric acid-lowering drugs in clinical practice in China are those which inhibit uric acid synthesis or promote uric acid excretion. Due to certain limitations in the efficacy and safety of the marketed uric acid-lowering drugs, such as causing renal failure, sudden cardiac death or severe liver toxicity. There is still an urgent need for effective and safe uric acid-lowering drugs among gout and hyperuricemia patients in China.ABP-671 is currently with the potential to be the promising and safe product for the treatment of gout and hyperuricemia. Through this collaboration, it fills the blank in the CMS's product portfolio of the treatment of gout. Gout and hyperuricemia are both rheumatic diseases and chronic metabolic diseases, which are highly consistent with the Group's strategic layout in the cardio-cerebrovascular/ gastroenterology business and the network resources of marketed products. If approved for marketing in the future, the Product will synergize with the Group’s marketed product Metoject (methotrexate injection) in rheumatology and with Elcitonin (elcatonin injection) in endocrinology and orthopedics, in terms of expert network and market resources. Based on the unmet clinical needs and the expected solid clinical data of the Product, the Group is looking forward to the smooth advancement of the clinical development of ABP-671, allowing patients with relevant indications to benefit from this innovative treatment sooner.About ATOM THERAPEUTICSAtom Therapeutics was founded in March 2012, focused on the research and development of innovative drugs with global commercial value and competitiveness in the metabolic and inflammatory area. Atom Therapeutics's main core team members come from the United States, with extensive experience in the research and development of innovative drugs. Atom Therapeutics has achieved remarkable development in the past few years. Atom Therapeutics's core product ABP-671 is under pivotal clinical stage for the treatment of chronic gout. Atom Therapeutics's another small molecule innovative drug named as ABP-745, used for indications in the field of anti-inflammatory immune indications. The Phase 1 clinical of ABP-745 exhibited outstanding pharmacokinetics and safety. The clinical trial is on the verge of entering Phase 2. For more information about Atom Therapeutics and its pipeline, please visit https://www.atombp.com/.About CMSCMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs.CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients.CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development of its advantageous specialty fields and expand business boundaries. While strengthening the competitiveness of the cardio-cerebrovascular/gastroenterology business, CMS independently operates its dermatology and medical aesthetics business, and ophthalmology business, aiming to gain leading positions in specialty therapeutic fields, whilst enhancing the scale and efficiency. At the same time, CMS has expanded its business territory to the Southeast Asian market, striving to become a "bridgehead" for global pharmaceutical companies to enter the Southeast Asian market, further escorting the sustainable and healthy development of the Group.Reference:1. The results of Phase 2 clinical trials was published and can be found at: https://www.atombp.com/2023/03/01/atom-bioscience-announces-positive-results-of-phase-2a-china-clinical-trial-of-its-urat1-inhibitor-for-chronic-gout/CMS Disclaimer and Forward-Looking StatementsThis press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert.This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.Media ContactBrand: China Medical System Holdings Ltd.Contact: CMS Investor RelationsWebsite: https://web.cms.net.cn/en/home/Source: China Medical System Holdings Ltd. Copyright 2024 ACN Newswire via SeaPRwire.com.

SAN DIEGO, CA, Dec 3, 2024 - (ACN Newswire via SeaPRwire.com) - On November 19, 2024, General Atomics Aeronautical Systems, Inc. (GA-ASI) hosted its first Blue Magic Netherlands (BMN) event in Eindhoven, the Netherlands. Approximately 200 people attended the event that provided Dutch businesses with an opportunity to present their capabilities to GA-ASI and other companies interested in possible collaborations. GA-ASI was joined for the event by the Netherlands Ministry of Economic Affairs, the Netherlands Ministry of Defence, Lockheed Martin Ventures, Brainport Development, Brabant Development Agency (BOM), the Netherlands Industries for Defence & Security (NIDV), and SpaceNED.At this event, GA-ASI and its partners heard first-hand from Dutch companies about the important capabilities they are developing. The process started in July when GA-ASI put out an open invitation to Dutch businesses to apply for the opportunity to present innovative technologies at the November 19 event. Key areas of focus included Artificial Intelligence/Machine Learning, Autonomy, Advanced Materials, Sensors, Advanced Manufacturing, and Space. Close to 50 companies applied and after reviewing the applications, 15 businesses were selected to pitch their capabilities to an audience that included lightweight lattice structures, gas detection technologies, advanced battery and photonics applications, and several innovative unmanned system and AI applications, among many others."This event is where the rubber meets the road," said Brad Lunn, Managing Director-Strategic Finance at GA-ASI. "In addition to attracting many companies, we increased the areas of expertise and depth of knowledge from the presenting companies in order to provide research, development, and breakthrough innovations to support current and future missions by GA-ASI aircraft. We also wanted to give the companies an opportunity to pitch in front of other potential customers, partners, and investors."The first Blue Magic event held by GA-ASI was in 2019 in Belgium, with subsequent events held in 2020, 2021, and 2023. GA-ASI is delivering eight MQ-9A Remotely Piloted Aircraft to the Royal Netherlands Air Force (RNLAF).GA-ASI expects to announce technology partnerships stemming from the BMN event and intends to hold this event on an annual basis in the Netherlands.About GA-ASIGeneral Atomics Aeronautical Systems, Inc. (GA-ASI), an affiliate of General Atomics, is a leading designer and manufacturer of proven, reliable remotely piloted aircraft (RPA) systems, radars, and electro-optic and related mission systems, including the Predator® RPA series and the Lynx® Multi-mode Radar. With more than eight million flight hours, GA-ASI provides long-endurance, mission-capable aircraft with integrated sensor and data link systems required to deliver persistent flight that enables situational awareness and rapid strike. The company also produces a variety of ground control stations and sensor control/image analysis software, offers pilot training and support services, and develops meta-material antennas. For more information, visit www.ga-asi.com.Avenger, Lynx, Predator, Reaper, SeaGuardian, and SkyGuardian are registered trademarks of General Atomics Aeronautical Systems, Inc.Contact InformationGA-ASI Media Relationsasi-mediarelations@ga-asi.comSource: General Atomics Aeronautical Systems, Inc. Copyright 2024 ACN Newswire via SeaPRwire.com.

HONG KONG, Dec 3, 2024 - (ACN Newswire via SeaPRwire.com) - December 2, 2024, In the context of the Belt and Road Initiative, the first Belt and Road Golden Route Series Financial Promotion Event——the Kyrgyz Republic Ministry of Finance's promotional seminar and non-deal roadshow was successfully held today in Hong Kong. The event was jointly hosted by TF International Securities Group Limited ("TF International") and China CITIC Bank International Limited ("China CITIC Bank International"), attracting numerous international investors and financial industry leaders.The Kyrgyz Republic, as one of the earliest countries to support and engage in the Belt and Road Initiative, has seen increasingly close economic and trade relations with China. Recently, TF International signed a memorandum of understanding with the Kyrgyz Republic Ministry of Finance, becoming the first Hong Kong-based Chinese securities firm to establish an official partnership with the Kyrgyz Republic Ministry of Finance. The two parties work together to promote the RMB internationalization, support the real economy, facilitate high-quality development, and reinforce Hong Kong’s position as an international financial center. The event featured distinguished guests, including Mr. Amanbaev Umutzhan Mominovich, Deputy Minister of Finance of Kyrgyz Republic, Mr. Abdybapov Abdanbek Abdybapovich, Head of the Government Borrowing Department of Kyrgyz Republic, Mr. CHAN Ho Lim, Joseph, JP, Under Secretary for Financial Services and the Treasury of Hong Kong S.A.R., and Mr. ZOU Chuan, CEO of TF International, as well as Mr. Andy Siow, Senior Coverage Banker, DCM, at China CITIC Bank International. They shared insights into Kyrgyzstan’s development opportunities and investment prospects in the international financial market, discussing investment opportunities and key focus areas for mutually beneficial cooperation. In his opening speech, Mr. CHAN Ho Lim, Under Secretary for Financial Services and the Treasury of Hong Kong, remarked, "Hong Kong has firmly established itself as Asia’s leading international financial centre. Our core strengths include free flow of capital and information, a robust common law system, and a simple and low tax regime, and Hong Kong enjoys preferential access to Mainland China. All these position Hong Kong as the super-connector between China and international markets, which plays a key role in promoting RMB internationalization and advancing the Belt and Road Initiative. The Kyrgyz Republic is an important partner under the Belt and Road Initiative and is certainly Hong Kong’s important trading partner in Central Asia.” He also stated that, “I would like to express my gratitude to the Kyrgyz Republic Ministry of Finance and TF International and appreciate your commitment to fostering stronger ties between Central Asia and Hong Kong. We look forward to exploring potential future collaborations with the Kyrgyz Republic that will benefit our respective markets and promote partnerships among Belt and Road nations.” As of September 1, 2024, Renminbi (RMB) has been included in the list of official daily exchange rates published by Kyrgyzstan, alongside the US dollar, euro, Russian ruble, and Kazakh tenge. This move further strengthens economic and financial cooperation between the two countries. Mr. Amanbaev Umutzhan Mominovich, Deputy Minister of Finance of the Kyrgyz Republic, stated, "The inclusion of the RMB in the list of official daily exchange rates in Kyrgyzstan marks a new stage in the economic cooperation between the two countries. This not only provides greater convenience for international investors but also empowers the development of Kyrgyzstan's financial market. Through this promotional event, we hope to connect with more international investment institutions and jointly promote the sustainable development of the regional economy." Hong Kong, as the international financial center and the central city of the Guangdong-Hong Kong-Macao Greater Bay Area, plays an important bridging role in the Belt and Road Initiative, leveraging its diverse financing channels and close alignment with national strategies. Mr. ZOU Chuan, CEO of TF International, stated, "The Belt and Road Initiative offers significant opportunities for economic integration and development, enhancing trade across Asia, Europe, the Middle East, and beyond. As a gateway between China and the world, Hong Kong is a key hub for the internationalization of the Renminbi, facilitating its use in trade and investment, and supporting effective currency risk management for BRI projects. With ongoing economic expansion and the internationalization of the Renminbi, Hong Kong is well-positioned to emerge as the premier financing hub. As we explore upcoming opportunities, I encourage you to envision the transformative impact these initiatives can have on the Kyrgyz Republic’s development agenda and the broader economic landscape of Central Asia. Together, we can unlock new avenues for growth and collaboration." From December 3 to 6, 2024, TF International, in collaboration with China CITIC Bank International will join forces with the Kyrgyz Republic Ministry of Finance in hosting a series of non-deal roadshows in Shanghai and Beijing, further strengthening ties with the Chinese financial market. The success of today’s promotional seminar and non-deal roadshow in Hong Kong marks a new milestone in the economic cooperation between the two countries and injects fresh momentum into the high-quality development of the Belt and Road Initiative. Copyright 2024 ACN Newswire via SeaPRwire.com.

London, UK, Dec 2, 2024 - (ACN Newswire via SeaPRwire.com) - The 3rd edition of the London Climate Technology Show concluded last week, paving a vital roadmap towards fully decarbonising our planet through sustainable technologies. The event brought together policymakers, eco-technology leaders, industry professionals, and innovators, all unified in their call for an immediate shift to sustainable and green solutions to secure a better future for the planet.The two-day event opened on 27th November with an inspiring keynote by Felicity Burch, Executive Director of the Responsible Technology Adoption Unit at the Department for Science, Innovation, and Technology (DSIT), who spoke about AI Innovation in Clean Energy and the DSIT's Manchester Prize. Following her, Ing. Abigail Cutajar, CEO of the Climate Action Authority, talked about Pioneering the Surge Towards Climate and Energy Transitions.The conference unfolded over two dynamic days, featuring a packed agenda of insightful presentations and engaging panel discussions. It delved into actionable strategies for decarbonisation, advancements in AgriTech, the evolving carbon market, eco-funds, energy, CCS, built environment and other groundbreaking innovations in climate technology.Notable discussions highlighted the need for farmers to balance carbon stewardship with food production over the next few decades, the importance of consistent government policies to enable businesses to plan and innovate effectively, and the urgency of addressing digital and engineering skill shortages to ensure a successful green energy transition. Industry experts also called for common sustainability metrics to measure corporate efforts fairly, emphasized the value of collaboration over competition to accelerate the green transition, and underscored the need for farmers to access landscape-level data to enhance biodiversity.The exhibition hall featured groundbreaking innovations and solutions in sustainability and climate technology, including carbon capture and storage (CCS) from companies like CGI and Terra CO2 Technology, carbon management and accounting solutions by Greenly and Gaia Carbon Accounting, and emerging climate technologies from innovators such as Nabla Flow and Luna 9. Other exhibitors showcased AI-driven solutions, sustainable energy systems, and innovative carbon reduction technologies, presenting a comprehensive snapshot of the future of climate tech.#CTS24 also hosted interactive side events, including startup acceleration programs and hands-on workshops, providing participants with opportunities for learning, networking, and collaboration. These sessions empowered attendees to adopt transformative technologies and take decisive climate action.Attendee ExperiencesThe event received overwhelming positive feedback:Mark Haley, Co-founder of Cero3, shared, "We’re so proud to have unveiled our sustainable travel planner. The feedback and interest exceeded our expectations."Satyajit Mohanan, Projects and Business Development Coordinator at Cambridge Cleantech, remarked, "It was a pleasure to be part of this event. I met amazing people and look forward to the next edition."Dennis Chacko, Senior Sales Manager at the British Board of Agreement, shared his excitement over a unique sustainable pen: "Once used, you can plant it to grow something new—a powerful reminder of how everyday items can contribute to a greener future."As this successful edition concludes, the organisers are already planning for a bigger, more impactful 4th Edition, with expanded content and greater opportunities to drive meaningful change toward a sustainable future.For further information, please reach out to us at press@valiantandcompany.com. Copyright 2024 ACN Newswire via SeaPRwire.com.

Highlights (relevant audited data for the year ended 31 August 2024)- Revenue increased by 17% YoY to approximately RMB2,312 million;- Gross profit rose by 10% YoY to approximately RMB1,124 million;- Profit for the period attributable to owners of the Company rose by 16% YoY to approximately RMB715 million;- Number of student enrolments increased by 11% YoY to approximately 95,600;- Payment of a final dividend of HK10.0 cents per share;- Dividend payout ratio of 30% for the year.HONG KONG, Nov 29, 2024 - (ACN Newswire via SeaPRwire.com) - Edvantage Group Holdings Limited (“Edvantage Group” or the “Group”, stock code: 0382.HK) has announced its audited FY2024 Annual Results for the year ended 31 August 2024 (the “Reporting Period”). During the Reporting Period, the Group actively responded to national policies, vigorously promoted industry-education integration, deepened the connotations of international education, continued to introduce unique new featured majors that match market and industry demands and fully embraced artificial intelligence (“AI”), succeeding in raising education quality and brand presence, thereby achieving steady growth in performance year after year.During the Reporting Period, the Group’s revenue totaled approximately RMB2,312 million, representing an increase of 17% as compared to the corresponding period of the preceding year. The increase was mainly attributable to the continuous enhancement of the Group’s education brand effectiveness, which drove a rise in the number of student enrolments and higher average tuition fees recorded by the Group’s domestic schools. Profit for the period attributable to owners of the Company rose by 16% YoY to approximately RMB715 million. The number of students enrolled in the Group’s schools continued to expand yearly, reaching approximately 95,600, with a year-on-year growth of approximately 11%. The Board of Directors of the Group has recommended the payment of a final dividend of HK10.0 cents per share for the year ended 31 August 2024, which, along with an interim dividend of HK9.6 cents per share, equates to a total annual dividend of HK19.6 cents per share and a dividend payout ratio of 30% for the year.From left to right: Mr. Yan Kwok Ting Sunny, Director of Investment, Corporate Finance & Investor Relations Department;Mr. Liu Yuk Tung, ChiefFinancial Officer; Ms. Liu Yi Man, Executive Director and Chief Executive Officer;Ms. Liu Wenqi, Chief Operating Officer;Fully embracing AI and continuously promoting the industry-education integrationOver the past year, the Group witnessed the groundbreaking development of the new generation of artificial intelligence technology. As a vocational education provider, the Group has developed in step with times, fully embracing AI in teaching, management and application. At present, all of its schools are actively promoting AI, fostering its popularity, with AI-embedded courses launched in seven colleges. Subsequent efforts will be made to promote those programmes to cover all faculties and students of all schools under the Group. Meanwhile, the Group actively responded to national policies, continuously deepened industry-education integration, and fully promoted the construction of industrial colleges, cooperating with multiple enterprises renowned in their respective industries to establish artificial intelligence and big data, digital trade, digitalised accounting and business services, research and tourism, jewelry, human resources and other industrial colleges. Those industrial colleges are all set up according to the Ministry of Education requirements for building modern industrial colleges that align with the country’s key industry development strategies, in order to nurture high-quality application-minded talent that emerging industries urgently need. In addition, the Group also entered into school-enterprise cooperation with numerous enterprises to build off-campus practice bases, further promoting the in-depth integration of education chains and industrial chains.Expanding exchange and cooperation of international education and deepening the connotations of international educationThe Group responded to the national advocacy for the opening up of education, “introduction of foreign schools”, and “international expansion of domestic schools”, continuously promoted the internationalisation of vocational education and expanded the partnership network with global renowned universities. By providing high-quality international programs and practice opportunities to students, the Group aims to cultivate innovative talents with global vision, to further raise the international influence of China’s vocational education. During the Reporting Period, the schools under the Group established in-depth cooperation with 51 foreign high schools in the United States of America, the United Kingdom, Canada, Japan and Australia, joining hands to create diverse high-quality international programmes. Furthermore, the Group comprehensively launched international study tours, organising 65 student and teacher study tours to France, Singapore, Hong Kong, China, Macau, China and other regions for short-term studies, with over 4,000 teachers and students participating during the Reporting Period. Looking forward, the Group will press on with deepening integration of its schools - domestic and international, strive to build a diversified international education cooperation network, actively promote Chinese vocational education to go global and build an internationally renowned Chinese vocational education brand.Consistently increasing investment in education to build a high-quality education brandThe Group has always adhered to the motto of "Establishing school of the century, Nurturing talents of the nation". Firmly believing that increasing investment in education is an important path towards high-quality education, the Group further expanded the new campus of Guangzhou Huashang College and Guangzhou Huashang Vocational College during the Reporting Period, which includes student dormitories, library, sports centre, teaching buildings and laboratories, providing solid support for future student enrollment and sustainable development of the Group. At the same time, it has kept increasing investment in building a high-quality teaching staff, which has expanded after the Guangzhou Huashang College and Guangzhou Huashang Vocational College established their Guangdong Province Doctoral Workstation respectively. The Group has launched a series of training workshops for teachers to continuously enhance their professionalism and practical teaching abilities, encouraging them to practice what they have learned and help improve school education and teaching quality. By introducing mentors from industries, it works together with enterprises in nurturing professional “dual-qualified” teachers and “dual-skilled” industry mentors, continuing to optimize the combined structure of full-time and part-time faculty teams. The in-depth and precise investment made by the Group in various areas crucial to strengthening school management has brought bountiful results. Guangzhou Huashang College placed third in scientific research competitiveness among private undergraduate colleges in China and has been designated as a key research base for humanities and social sciences among regular higher education institutions in Guangdong Province. Guangzhou Huashang Vocational College has been named a national exemplary vocational college, while the Urban Vocational College of Sichuan ranked second in China and first in Sichuan among Shanghai Ranking's 2024 Best Chinese Private Higher Vocational Colleges. These honors are a strong testament to the Group’s high-quality educational achievements.Looking ahead, the Group will continue to nurture innovative talent, focusing on such areas as industry and education integration, internationalization, and AI to keep up with industry and social development needs, increase investment in education, and keep building a high-quality education brand. It is committed to nurturing highly-skilled interdisciplinary corporate leaders for the country and industries around the world, while continuously making positive contributions to the sustainable development of vocational education.About Edvantage Group Holdings LimitedEdvantage Group Holdings Limited (“Edvantage Group” or the “Group”, stock code: 0382.HK) is the largest private business higher education and vocational education group in the Greater Bay Area, and an early mover in education sector in pursuing international expansion, listed in Hong Kong Main Board on 16 July 2019. The total number of full-time student enrolments of the Group was approximately 96,000 as of 31 August 2024. Operated 9 private education institutions, namely, Guangzhou Huashang College (Applied Undergraduate), Guangzhou Huashang Vocational College (Higher Vocational Education) and Guangdong Huashang Technical School (Secondary Vocational Education) located in Guangdong Province, the PRC; Urban Vocational College of Sichuan (Higher Vocational Education) and Urban Technician College of Sichuan (Secondary Vocational Education) in Sichuan Province, the PRC; GBA Business School (GBABS) in Hong Kong, the PRC; Global Business College of Australia (GBCA) and Edvantage Institute Australia (EIA) in Australia; as well as Edvantage Institute (Singapore) (EIS) in the downtown of Singapore.While focusing on school operations, the Group also actively fulfil corporate social responsibility, extensively contributing to social welfare programmes including charity, poverty alleviation, education and revitalisation, in order to take the initiative in repaying society through action. Since its listing, the Group has made outstanding contributions in the field of ESG and has won the “Best ESG Innovation Award” from Zhitong Finance and the “Outstanding Enterprise for ESG Innovative Practice” from Gelonghui in 2024. Copyright 2024 ACN Newswire via SeaPRwire.com.

HONG KONG, Nov 29, 2024 - (ACN Newswire via SeaPRwire.com) - The Hong Kong Institute of Directors ("HKIoD") announced the winners of its Award Series for Director Excellence (the "Awards") – comprising the long-established Directors of the Year Awards ("DYA") and the inaugural Climate Governance Awards ("CGA"), at its Annual Dinner yesterday at the Hong Kong Convention and Exhibition Centre. The event began with an opening speech by Dr Christopher To, Chairman of the HKIoD. Dr The Hon Moses Cheng Mo Chi, Non-official Member of the Executive Council of HKSARG, Mr Xu Wei Gang, Director General, Department of Economic Affairs, Liaison Office of the Central People's Government in HKSAR, Ms Salina Yan, JP, Permanent Secretary for Financial Services and the Treasury (Financial Services), and Dr Kelvin Wong, Chairman, Securities and Futures Commission ("SFC") and Chairman, Accounting and Financial Reporting Council ("AFRC") were invited as guests of honour. The response to the Awards submissions was overwhelmingly positive. After a lively discussion among the judges, this year's 19 winners, including directors and boards, were selected - all embodying the theme "Leading with Agility in an Era of Innovation". The awardees have demonstrated not only agility, but also the vision, courage and wisdom to lead against the backdrop of a demanding economic environment and prevailing geopolitical tensions. Moreover, they highlight the importance of having directors who can guide their companies in identifying the risks and opportunities associated with climate change, which are vital for ensuring the sustainability of the world and humanity.The Awardees of HKIoD Award Series* for Director Excellence 2024 are listed below:*Two series of Awards:- "DYA", acronym for "Directors Of The Year Awards"- "CGA", acronym for "Climate Governance Awards"In alphabetical order of names within categoryListed Companies CategoriesExecutive DirectorsDYAMr Chan Wai MingTown Ray Holdings LimitedCGAMs Clara Chan Yuen-shanLee Kee Holdings LimitedDYAMr Fu FanChina Pacific Insurance (Group) Co., LtdCGA Mr Li Wai LeungHengan Internationals Group Company LimitedMr Peter Wong Wai-YeeThe Hong Kong and China Gas Company LimitedDYA & CGAMr Yan Jianguo JPChina Overseas Land & Investment LimitedNon-Executive DirectorsDYA Dr Chung Shui Ming TimpsonChina Railway Group LimitedDr Tseng Shieng-chang CarterTCL Electronics Holdings LimitedProf Wang YijiangTCL Electronics Holdings LimitedBoardsDYA & CGAChina Resources Beer (Holdings) Company LimitedCGAHong Kong and China Gas Company LimitedDYA & CGAPing An Insurance (Group)Company of China, LtdCGAUnited Company RUSAL, international public joint-stock companyNon-listed Companies CategoriesExecutive DirectorsDYAMs Michelle ChanAS Watson IndustriesCGA Ir Prof Daniel M.ChengDunwell Technology (Holdings) Limited) (Dunwell Group)Ir Dr Cheng Sai Yau, VincentArup Fellow and Director of Climate and Sustainability in East AsiaDYAMr Orr Ka-yeung KevinWinner Medical (Hong Kong) LtdStatutory/ Non-profit-distributing Organisations CategoriesBoardsDYAHong Kong Tourism Board*In addition: recognition of Excellence in Board DiversityThe Institute of Internal Auditors Hong Kong*In addition: recognition of Excellence in Board DiversityThe guests of honour, special guests and officials to join the group photos together with the awardees (2nd row).About "HKIoD Award Series for Director Excellence"The HKIoD Award Series for Director Excellence is a project organised by The Hong Kong Institute of Directors ("HKIoD") and consists of two series of Awards.The first series, Directors Of The Year Awards, was inaugurated in 2001 as the first ever such Awards organised in Asia. As directors are ultimately responsible for corporate governance and leading the company in prosperity and integrity, the objectives of the Awards are to recognise outstanding boards and directors and to promote good practices in corporate governance and director professionalism. The Awards have become an annual project of impact in the community organised by HKIoD together with over 100 Project Partners. To date, 255 Awardees have been recognised for their achievements in demonstrating exemplary high standards in corporate governance and director practice.Inaugurated in 2024, Climate Governance Awards constitute the second series of HKIoD Awards with the objectives to recognise and inspire exemplary achievements in climate governance and to advocate climate action by directors. There are 10 awardees who have been acknowledged in the inaugural edition of the awards. It is critical time now for directors to address the risks and opportunities of climate change in board agendas and their governance role.Candidates are open to public nomination, with data processed in well-defined and stringent procedures, followed by interviews with independent consultants in utmost due diligence and finally selected by independent judges with high standards and fair judgment. Awards are presented by company categories, viz Listed Companies, Non-listed Companies and Statutory/Non-profit-distributing Organisations, and by capacities, viz Executive Directors, Non-Executive Directors and Boards.About The Hong Kong Institute of Directors ("HKIoD")The Hong Kong Institute of Directors ("HKIoD") is Hong Kong's premier body representing directors working together to advance corporate sustainability in creating long-term value for companies, their owners, stakeholders, humankind and Planet Earth through advocacy and standards-setting in corporate governance and director professionalism. Led by Founder Chairman Dr The Hon Moses Cheng, HKIoD was founded in 1997. Throughout the years, HKIoD is honoured to have the Chief Executive of HKSAR as the Institute's Patron. Membership of HKIoD comprises of directors from diverse industries and corporate types and includes Executive Directors, Non-Executive Directors and Independent Non-Executive Directors. With multi-culturalism and international perspectives, HKIoD organises activities that cover director training, seminars and forums, collective director voice, guideline establishment, public education, Award Series for Director Excellence, assessment of Corporate Governance Scorecard for listed companies etc.As a member body of the Global Network of Director Institutes ("GNDI"), HKIoD is committed to global collaboration in promoting good corporate governance and director professionalism. HKIoD is the appointed Host of the Hong Kong Chapter of Climate Governance Initiative, a global network that collaborates with the World Economic Forum in actively promoting directors' address of the risks and opportunities of climate change.For details please visit:http://www.hkiod.com|http://www.gndi.org|https://climate-governance.org/Media Enquiries:Award Series for Director Excellence:Strategic Public Relations Group LimitedThe Hong Kong Institute of DirectorsBrenda Chan+852 2114 4396/ brenda.chan@sprg.com.hkOdessa So +852 2889 4988/ odessa.so@hkiod.com Copyright 2024 ACN Newswire via SeaPRwire.com.

LONDON, Dec 2, 2024 - (ACN Newswire via SeaPRwire.com) - Spritzer has once again demonstrated its dominance in the bottled water industry by being named "Brand of the Year" in the national beverage division’s Water Category at the prestigious 2024–2025 World Branding Awards. The recognition marks Spritzer’s 10th consecutive win at the global awards, a testament to the brand’s enduring excellence in quality, branding, and consumer trust which further solidifies its position as Malaysia’s leading mineral water brand.Spritzer’s Head of Public Relations, Winnie Chin, accepting the Brand of the Year award under the national beverage division’s Water Category during the recent World Branding Awards at the Tower of LondonThe accolade was awarded by the World Branding Forum (WBF), a global non-profit organization devoted to advancing branding standards worldwide, at the annual World Branding Awards event which recognizes exceptional global and national brands across various categories. Winners in each category were evaluated through a rigorous process involving brand valuation, market research, and online public voting, showcasing a holistic assessment of brand strength and consumer trust. Most importantly, as the award evaluation relies heavily on consumer voting (70%), Spritzer’s continued wins over the years demonstrates the brand’s ability to consistently resonate with audiences and exceed customer expectations.Accepting the award on behalf of Spritzer during the awards ceremony held at the iconic Tower of London was Winnie Chin, Spritzer’s Head of Public Relations, who acknowledged the profound significance of this milestone: “We are honoured to receive this award for the 10th year running. Our achievements would not be possible without the unwavering support of our consumers, whose steadfast loyalty has made the Spritzer brand a household name. We also extend our gratitude to our partners for their collaboration and support and especially to our dedicated team for their hard work and creativity that have made this journey possible. We are deeply humbled and motivated to continue elevating our brand to greater heights, to build on Spritzer’s brand strength and commitment to excellence in all aspects of our company.”The award is a milestone that recognises Spritzer as a benchmark for consistency and adaptability to maintain brand trust and address emerging consumer needs in the ever-evolving market landscape. The company’s consistency, adaptability, and innovation have not only propelled it to the forefront of Malaysia’s bottled water industry but have also established it as a benchmark for quality, sustainability and innovation on a global stage. Spritzer’s decade-long winning streak at the awards exemplifies the brand’s commitment to producing high-quality natural bottled water and its reputation as a consumer-preferred brand.Building on this monumental achievement, Spritzer reaffirms its commitment to quality assurance as it continues to deliver bottled water with natural benefits and premium standards. The brand emphasises its dedication to sustainability goals and innovation as it continues to focus on advancing efforts to become a circular brand by 2030, aligned with global environmental initiatives, while leveraging cutting-edge technologies to introduce consumer-focused solutions to meet emerging needs.For more details about Spritzer, please visit our website at https://www.spritzer.com.my/.About Spritzer:Established in 1989, Spritzer Group has been a pioneer in providing Malaysians with natural mineral water sourced from a 440-acre green rainforest. Committed to innovation, Spritzer Group leads the Malaysian bottled water industry through manufacturing, distribution, marketing, and sales of its diverse product line. From renowned natural mineral water to refreshing non-carbonated fruit-flavoured drinks, each product is carefully crafted to meet consumer needs.Comprising eight business subsidiaries, Spritzer Group specializes in the production and distribution of silica-rich natural mineral water, sparkling natural mineral water, distilled drinking water, carbonated fruit-flavoured drinks, and non-carbonated fruit-flavoured drinks.With over 30 years of experience, Spritzer Group is Malaysia's largest and only listed bottled water producer. For more information, please visit www.spritzer.com.my. Copyright 2024 ACN Newswire via SeaPRwire.com.

SHANGHAI, Dec 2, 2024 - (ACN Newswire via SeaPRwire.com) - Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that Department of Health of the Government of the Hong Kong Special Administrative Region, China, has accepted Everest’s New Drug Application (NDA) for VELSIPITY(R) (etrasimod) for the treatment of adult patients with moderately to severely active ulcerative colitis. VELSIPITY(R) is an effective and convenient, once-daily, oral treatment for patients with moderately-to-severely active UC that has already been approved in the U.S. and E.U., and other countries, by Everest’s licensing partner, Pfizer. In Everest territories, the Pharmaceutical Administration Bureau of the Macau Special Administrative Region, China has approved the NDA for VELSIPITY(R) in April of this year and was implemented in the Guangdong-Hong Kong-Macau Greater Bay Area this October through the "Hong Kong and Macau Medicine and Equipment Connect" policy."Autoimmune disease is a core focus and a significant growth driver for our company. The number of UC patients in China is projected to double from 2019 to 2030 to approximately one million, highlighting the urgent need for novel treatments." said Rogers Yongqing Luo, Chief Executive Officer of Everest Medicines. “Previously, VELSIPITY(R) has already been approved in Macau, China, and was implemented in the Greater Bay Area through the connect policy. The company also plans to submit the NDA for approval by China’s National Medical Products Administration (NMPA) this year, with the aim of benefiting more Chinese patients as soon as possible."" This is an important advancement for etrasimod, bringing hope to patients in Hong Kong, China. This new-generation S1P receptor modulator is an oral, once-daily treatment that can provide patients with a chance for corticosteroid-free remission, mucosal healing, and rapid symptom relief, " said Prof. Wu Kaichun with the First Affiliated Hospital of AFMU who is the principal investigator for etrasimod’s Asia clinical trial. “We hope China and other Asian countries can obtain approvals as soon as possible to benefit more patients."The acceptance of the NDA was based on results from the ELEVATE UC Phase 3 registrational program (ELEVATE UC 52 and ELEVATE UC 12) that evaluated the safety and efficacy of etrasimod 2 mg once-daily on clinical remission in UC patients with moderately to severely active UC who had previously failed or were intolerant to at least one conventional, biologic, or Janus kinase (JAK) inhibitor therapy. Nearly two-thirds of patients in ELEVATE UC 52 and ELEVATE UC 12 were naïve to biologic or JAK inhibitor therapy, and these studies were also the only studies for advanced therapies for ulcerative colitis to include patients with isolated proctitis. Both studies achieved all primary and key secondary efficacy endpoints, with a favorable safety profile consistent with previous studies of etrasimod.Everest conducted a multicenter, randomized, double-blind and placebo-controlled Phase 3 trial of etrasimod in Asian countries, including mainland China, China Taiwan and South Korea. This is the largest Phase 3 trial of moderately-to-severely active ulcerative colitis in Asia completed to date, with 340 eligible subjects randomized to treatment with etrasimod or placebo. The previously announced results of the induction period indicate that the clinical remission rate for patients treated with etrasimod 2mg was 25.0%, compared to 5.4% for those treated with placebo (difference 20.4%, p

Vancouver, British Columbia--(ACN Newswire via SeaPRwire.com - November 28, 2024) - Military Metals Corp. (CSE: MILI) (OTCQB: MILIF) (FSE: QN90) (the "Company" or "MILI") is pleased to report that it has completed additional staking of claims surrounding the Last Chance antimony-gold property, located in Nye County, Nevada, just over 70km north of the town of Tonapah and 12km due west of Kinross' Round Mountain gold mine. The Company recently entered into a letter of intent to acquire the Last Chance antimony-gold property. Please refer to the Company's news release dated November 14, 2024, for additional details about the Last Chance property.Scott Eldridge, Chief Executive Officer of the Company, commented, "Antimony prices have now risen to $38,000 USD per tonne, making antimony the top performing commodity thus far for 2024. China's export restriction that came into play September 15, 2024, has created a supply crunch that has magnified the need for domestic development of defense sector metals. This additional staking solidifies complete coverage of what we believe is the entire mineralized system surrounding the Last Chance antimony-gold property."Location map, Last Chance PropertyTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/10818/231755_11f4bf32b4999b42_001full.jpgHistorical antimony-gold occurrences and a solitary shaft where limited historical production is recorded occur within a sequence of Paleozoic carbonates and Lower Mesozoic metamorphosed shales and carbonates; A series of ultramafic dykes as well as younger felsic intrusives and extrusives cut this sequence at several locations. Mineralization is structurally controlled, with folding, faulting and quartz veining seen throughout the metamorphosed sedimentary sequence at several locations across the property.A fence of claims was staked surrounding the Last Chance property to ensure that additional ground considered potentially prospective remains available to the Company when it begins its first field campaign scheduled for Q2/2025.The technical contents of this release were reviewed and approved by Avrom E. Howard, MSc, PGeo, geological consultant to Military Metals and a qualified person as defined by NI 43-101.About Military Metals Corp. The Company is a British Columbia-based mineral exploration company that is primarily engaged in the acquisition, exploration and development of mineral properties with a focus on antimony.ON BEHALF OF THE BOARD of DIRECTORSFor more information, please contact:Scott EldridgeCEO and Directorscott@militarymetalscorp.comFor enquiries, please call 604-722-5381 or 604-537-7556This news release contains "forward-looking information". Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates", or "believes" or variations (including negative variations) of such words and phrases, or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward-Looking information in this news release includes statements related to the completion of a binding agreement and closing of the acquisition of the Last Chance Gold Property, as well as future plans for exploration activities, and assumptions related to the continuation of the global demand for antimony. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this news release. These include meeting the conditions to close the acquisition of the Last Chance Gold Property, geopolitical developments related to the supply of antimony, the continued use of antimony and availability of alternatives, availability of capital and labour in respect of the properties that are the subjects of this news release, the results of any future exploration activities, which cannot be guaranteed, and such other factors as may impact both and any future activities in respect of the properties. Additional risk factors can also be found in the Company's public filings under the Company's SEDAR+ profile at www.sedarplus.ca. Forward-Looking statements contained herein are made as of the date of this news release and the Company disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events or results or otherwise. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. The Company undertakes no obligation to update forward looking statements if circumstances, management's estimates or opinions should change, except as required by securities legislation. Accordingly, the reader is cautioned not to place undue reliance on forward-looking statements.The Canadian Securities Exchange has neither approved nor disapproved the information contained herein and does not accept responsibility for the adequacy or accuracy of this news release.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/231755 Copyright 2024 ACN Newswire via SeaPRwire.com.

KUALA LUMPUR, Nov 26, 2024 - (ACN Newswire via SeaPRwire.com) - GoKardz, a trailblazing platform in digital business networking, proudly announces the launch of its Enterprise Module, an innovative solution designed to empower companies to create their company pages, onboard employees seamlessly, and maximize the potential of digital business cards. This addition merges traditional networking with advanced digital solutions to enhance connectivity and maintain brand identity, all while giving companies full control over their organizational presence.Enterprise Solutions for Modern BusinessesWith GoKardz’s Enterprise Module, companies can create customized company profiles and onboard employees effortlessly, equipping them with unique and customizable digital business cards that reinforce their brand identity. Employers gain full control over onboarding, ensuring a smooth, centralized process that guarantees all employees are equipped and up-to-date.Beyond individual digital business cards, businesses can now:Promote Products and Services: Increase brand exposure and engagement through GoKardz’s marketplace, showcasing offerings for maximum visibility.Advertise Open Positions: Post full-time, contractual, or freelance job opportunities, attracting top talent to meet business needs.Leverage Analytics: Gain actionable insights into visitor interactions, such as views of employee cards and clicks on links (e.g., website, email, phone), analytics that were previously impossible with traditional paper business cards.Reallocate Cards: Seamlessly transfer cards to new employees during transitions, maintaining continuity without any gaps in information.Seamless Digital ExperienceThe platform’s intuitive interface ensures companies can manage their digital assets and branding consistently across the organization. Employees can easily share their digital business cards through QR codes, NFC technology, Apple Wallets, and other methods, facilitating instant, scalable sharing while reducing environmental impact from traditional business cards.A Sustainable and Data-Driven Approach to NetworkingAs businesses increasingly turn to digital solutions, GoKardz leads the way in aligning technological innovation with environmental responsibility. By embracing digital business cards, companies not only improve their networking efficiency but also take a step towards sustainability. The analytics tools further support data-driven decision-making, empowering businesses to refine their outreach strategies based on real-time engagement metrics.A Word from Our LeadersAmaresh, Co-Founder of GoKardz, shared his vision:“At GoKardz, we’re committed to redefining professional networking with sustainable, data-driven solutions. Our enterprise tools help businesses modernize, reduce their environmental footprint, and optimize outreach strategies for greater impact.”Kuber Ventures, the venture studio that invested in GoKardz, emphasized:“Our investment in GoKardz stems from its ability to address a key gap in digital networking. The new Enterprise Module amplifies this vision by providing companies with innovative and efficient solutions that foster sustainable business growth.”With GoKardz, companies can confidently modernize their approach to networking, reduce their environmental impact, and gain valuable insights previously lost with traditional methods.GoKardz is available on iOS and Android, ready to transform the way professionals and businesses network and grow.For more information, visit www.gokardz.comMedia Contact: komal@mianext.com Copyright 2024 ACN Newswire via SeaPRwire.com.

SHANGHAI, Nov 30, 2024 - (ACN Newswire via SeaPRwire.com) - Hua Medicine (the “Company”, HKEx stock code: 2552) announced today that the Company has successfully completed a Phase I clinical trial on its 2nd generation GKA candidate in U.S. at the 9th China BioMed Innovation and Investment Conference (CBIIC).The Phase Ia clinical trial of the second-generation GKA (HM-002-1005) was conducted in the United States in 40 subjects with Type 2 diabetes (T2D). This trial was randomized, double-blind, placebo-controlled, single-dose, focusing on safety, tolerability, and pharmacokinetics. The second-generation GKA is a novel molecular entity with optimized physicochemical properties, holding new patents, and serving as the prodrug of dorzagliatin (HMS5552). This study designed for once-daily oral administration. Its aim is to extend the drug's action duration in the body through sustained-release technology, enhance patient compliance, and prolong the stimulation of GLP-1 secretion in the intestines.The Single Ascending Dose (SAD) study demonstrates that HM-002-1005 tablets can be rapidly converted to HMS5552 in the human body, with minimal exposure level of prodrug in both blood and urine. The t1/2 (biological half-life) after a single dose of HM-002-1005 tablets was prolonged compared to dorzagliatin tablets. The Cmax of HMS5552 in plasma after a 184.5mg single dose is comparable to the plasma concentration of HMS5552 after a 75mg single dose of dorzagliatin tablet; likewise, the daily AUC of HMS5552 in plasma after a single dose of HM-002-1005 tablets is comparable to the exposure level of HMS5552 after a 75mg BID dose of dorzagliatin tablets. The research indicates that HM-002-1005 tablets are near-completely converted to HMS5552 in human, and its pharmacokinetic characteristics support for once-daily oral administration. The development of HM-002-1005 tablets not only contributes to enhancing patient medication adherence and effectively control blood glucose levels within 24 hours; meanwhile, it also offers the opportunity to explore the Maximum Tolerated Dose above 150mg daily to achieve better efficacy. The 75 mg BID dose regiment was developed under the concept of Minimum Therapeutic Effective Dose in Chinese T2D patients who suffered from an impairment of insulin secretion and significant reduction of early phase insulin. The different disease characters of T2D with obesity in western patient population would benefit dorzagliatin from its effects on GLP-1 secretion and improvement of insulin sensitivity.With the confirmation that the exposure level of HM-002-1005 tablets at 184.5mg is comparable to dorzagliatin tablets at 75mg (BID), we will further optimize the dosage form followed by a Multiple Ascending Dose (MAD) clinical development of the 2nd generation GKA in China and the United States.Dr. Li CHEN, founder and CEO of Hua Medicine, stated, “Hua Medicine has always been committed to treating Type 2 diabetes at its root cause by restoring patients’ ability to autonomously regulate blood glucose levels. Over the course of a decade, the Company has selected dosing and clinical research protocols that are safe and effective for the majority of Chinese diabetes patients, leading to the successful development of GKA and the clinical application of dorzagliatin. Building on this foundation, the Company will undergo a strategic upgrade by further exploring the therapeutic potential of GKA, enriching its product pipeline and seeking partners both domestically and internationally, in order to benefit a broader range of patients, expand into global markets, and effectively establish the brand identity of GKA medications while maximizing the commercial potential of our global first-in-class drugs.”About Hua MedicineHua Medicine (The “Company”) is an innovative drug development and commercialization company based in Shanghai, China, with companies in the United States and Hong Kong. Hua Medicine focuses on developing novel therapies for patients with unmet medical needs worldwide. Based on global resources, Hua Medicine teams up with global high-calibre people to develop breakthrough technologies and products, which contribute to innovation in diabetes care. Hua Medicine's cornerstone product HuaTangNing (Dorzagliatin tablets), targets the glucose sensor glucokinase, restores glucose sensitivity in T2D patients, and stabilizes imbalances in blood glucose levels in patients. HuaTangNing was approved by the National Medical Products Administration (NMPA) of China on September 30th, 2022. It can be used alone or in combination with metformin for adult T2D patients. For patients with chronic kidney disease (CKD), no dose adjustment is required. It is an oral hypoglycemic drug that can be used for patients with Type 2 diabetes with renal function impairment.For more informationHua MedicineWebsite: www.huamedicine.comInvestorsE-mail: ir@huamedicine.comMediaE-mail: pr@huamedicine.com Copyright 2024 ACN Newswire via SeaPRwire.com.

SHANGHAI, Nov 30, 2024 - (ACN Newswire via SeaPRwire.com) - Hua Medicine (the “Company”, HKEx stock code: 2552) announced today that the Company has successfully completed its SENSITIZE study on the mechanism by which dorzagliatin improves the β-cell glucose sensitivity at the 9th China BioMed Innovation and Investment Conference (CBIIC).The SENSITIZE study was initiated by Professor Juliana Chan, an international endocrinology specialist at The Chinese University of Hong Kong, as the lead researcher. It is the first clinical study in Asian populations to evaluate the impact of GKA on β-cell glucose sensitivity in the populations with varying degrees of impaired glucose tolerance using the technology of hyperglycemic clamp. The study aims to explore the impairment of glucokinase (GK) function and clinical characteristics in different types of glucose dysregulation, providing new scientific evidence on the pathophysiology of Asian Type 2 diabetes and the central role of GK in blood glucose regulation.The SENSITIZE 2 study results announced at CBIIC demonstrate that a single dose of dorzagliatin restores GK enzyme activity, significantly improving the second-phase insulin secretion and β-cell glucose sensitivity in individuals with impaired glucose tolerance (IGT) in hyperglycemic clamp study. In addition, the SENSITIZE 1 study previously reported at the 2022 ADA annual meeting showed that dorzagliatin directly restores the activity of GK mutants, leading to significant improvements in the second-phase insulin secretion and β-cell glucose sensitivity in patients with glucokinase monogenic diabetes (GCK-MODY or MODY-2), and significantly enhance basal insulin secretion in newly diagnosed type 2 diabetes patients.Hua Medicine will continue to investigate β-cell glucose sensitivity improvement and incretin effect in response of repeated dose of dorzagliatin in individuals with intermediate hyperglycemia (IH) and Type 2 diabetes, in order to establish personalized intervention and treatment management plans for prediabetic and Type 2 diabetes patients.About Hua MedicineHua Medicine (The “Company”) is an innovative drug development and commercialization company based in Shanghai, China, with companies in the United States and Hong Kong. Hua Medicine focuses on developing novel therapies for patients with unmet medical needs worldwide. Based on global resources, Hua Medicine teams up with global high-calibre people to develop breakthrough technologies and products, which contribute to innovation in diabetes care. Hua Medicine's cornerstone product HuaTangNing (Dorzagliatin tablets), targets the glucose sensor glucokinase, restores glucose sensitivity in T2D patients, and stabilizes imbalances in blood glucose levels in patients. HuaTangNing was approved by the National Medical Products Administration (NMPA) of China on September 30th, 2022. It can be used alone or in combination with metformin for adult T2D patients. For patients with chronic kidney disease (CKD), no dose adjustment is required. It is an oral hypoglycemic drug that can be used for patients with Type 2 diabetes with renal function impairment.For more informationHua MedicineWebsite: www.huamedicine.comInvestorsE-mail: ir@huamedicine.comMediaE-mail: pr@huamedicine.com Copyright 2024 ACN Newswire via SeaPRwire.com.

KUCHING, MALAYSIA, Nov 28, 2024 - (ACN Newswire via SeaPRwire.com) - Industrialised building systems specialist, Sarawak Consolidated Industries Berhad ("SCIB" or the "Company") is pleased to announce its unaudited financial results for the first quarter of the fiscal year 2025 (“Q1 FY2025”). The Company reported a revenue of RM45.1 million, marking a 14.6% year-on-year increase compared to RM39.4 million in Q1 FY2024. The growth in revenue is largely due to the increased recognition of construction works done from ongoing projects. Ku Chong Hong, Managing Director of SCIBAs for Q1FY2025, SCIB's Manufacturing division continues to play a pivotal role in the Company’s performance, contributing RM32.5 million to the total revenue, a 9.9% increase from RM29.6 million in Q1 FY2024. This growth was primarily driven by increased sales of foundation piles and Industrialised Building System (“IBS”) products, especially for major projects such as the Kuching Urban Transportation System (“KUTS”), the Sarawak Second Trunk Road (“STR”) and school projects in Sarawak.Profit Before Tax (“PBT”) for the manufacturing segment stood at RM3.8 million. Meanwhile, the Construction/Engineering, Procurement, Construction and Commissioning (“EPCC”) division reported revenue of RM12.6 million, an increase from RM9.8 million in the same quarter last year. However, the segment recorded a Loss Before Tax (“LBT”) of RM2.0 million due to unanticipated unrealised foreign exchange loss recognised. The division remains focused on delivering ongoing projects while exploring new opportunities for expansion.During the quarter, SCIB maintained its commitment to strengthening its financial foundation and broadening its project portfolio. Additionally, SCIB had recently acquired a 2.49-hectares land parcel at Bintulu Sibiu Road, Bintulu, for RM9.2 million, followed by another parcel of 7.3-hectares land in Jalan Bintulu-Sibu as part of its plan to collaborate with developers for residential housing projects that utilise SCIB’s high-quality products and industry expertise, while expanding SCIB’s products and services offering to serve the fundamental needs of the Sarawak market.Mr. Ku Chong Hong, Managing Director of SCIB, commented, “The results of Q1 FY2025 reflect the challenges of a dynamic economic environment. However, we remain steadfast in our commitment to strengthening the financial foundation of the Company. Besides targeting to secure projects consistently, the recent securing of financial facilities from SME Bank and the proposed private placement of 10.0% of SCIB’s total issued shares underscore our focus on enhancing our cash position and ensuring financial stability to support our operational and strategic initiatives."Looking ahead, SCIB remains optimistic about Malaysia’s construction sector, bolstered by the record allocation in Budget 2025 of RM421 billion, including RM86 billion for development expenditure. The RM5.9 billion allocated for Sarawak, aimed at upgrading public infrastructure such as schools, healthcare centres, and airports, as well as large-scale projects like the Sabah-Sarawak Link Road (“SSLR”) and the North Coastal Highway, aligns seamlessly with SCIB’s expertise and strategic direction. The Company is poised to leverage its manufacturing capabilities and strategic initiatives to secure a strong foothold in both local and regional markets, ensuring sustainable growth and long-term value for its stakeholders.ABOUT SARAWAK CONSOLIDATED INDUSTRIES BERHADSarawak Consolidated Industries Berhad (“SCIB”) was founded in 1975 and has evolved from a small enterprise into a reputable Group of companies listed on the Main Market of Bursa Malaysia Securities Berhad. Currently, SCIB is operating three factories in Kuching, Sarawak, one factory in the Pending Industrial Estate and two factories in the Demak Laut industrial park.SCIB is well known for professional management and has long history of innovative ideas and technological advances. Coupled with its wealth of experience and research acquired in more than three decades, SCIB offers its clients in-depth expertise through a combination of technology, efficiency and speed.For more information, visit scib.com.my.Issued By: Swan Consultancy Sdn. Bhd. on behalf of Sarawak Consolidated Industries BerhadFor more information, please contact:Jazzmin WanEmail: j.wan@swanconsultancy.bizStephanie ChowEmail: s.chow@swanconsultancy.biz Copyright 2024 ACN Newswire via SeaPRwire.com.

KUALA LUMPUR, Nov 27, 2024 - (ACN Newswire via SeaPRwire.com) - Cropmate Berhad (“Cropmate” or the “Company”), a key player in the conventional and specialty fertiliser manufacturing industry in Malaysia, is pleased to announce that its Initial Public Offering (IPO) for the Malaysian public has been oversubscribed by 84.88 times, indicating strong investor interest in Cropmate’s growth trajectory and prospects.Managing Director of Cropmate Berhad, Mr. Lee Chin YokCropmate’s IPO of 260.00 million ordinary shares (“IPO Shares”) consists of a Public Issue of 210.00 million new ordinary shares (“Issue Shares”) and an Offer for Sale of 50.00 million shares (“Offer Shares”) involving:(I) Institutional offering of 208.34 million IPO Shares in the following manner:158.34 million Issue Shares allocated via private placement to institutional and selected investors, including 42.25 million Issue Shares approved for Bumiputera investors by the Ministry of Investment, Trade and Industry (“MITI”); and50.00 million Offer Shares allocated via private placement for Bumiputera investors by the MITI.(II) Retail offering of 51.66 million IPO Shares in the following manner:36.90 million Issue Shares made available for application by the Malaysian public via balloting, with an equal allocation between Bumiputera and non-Bumiputera investors; and14.76 million Issue Shares reserved for application by the eligible directors of the Company, employees of Cropmate and its subsidiary (“Group”) and persons who have contributed to the success of the Group (“Eligible Persons”).The Group received a total of 21,392 applications for 3,169,052,100 Issue Shares with a value of approximately RM633.81 million were received from the Malaysian public, which represents an overall oversubscription rate of 84.88 times. For the Bumiputera portion, a total of 10,745 applications for 1,368,843,700 Issue Shares were received, which represents an oversubscription rate of 73.19 times. For the public portion, a total of 10,647 applications for 1,800,208,400 Issue Shares were received, which represents an oversubscription rate of 96.57 times.The 14.76 million Issue Shares made available for application by the Eligible Persons were fully subscribed.Under the Institutional Offering of 208.34 million of IPO Shares, the Bookrunner has confirmed that it has received interests to subscribe the 158.34 million Issue Shares allocated via private placement to institutional and selected investors, including 42.25 million Issue Shares for Bumiputera investors by the MITI, as well as 50.00 million Offer Shares allocated via private placement for Bumiputera investors by the MITI.Managing Director of Cropmate Berhad, Mr. Lee Chin Yok, expressed, “The robust response to our IPO reflects the trust that investors have placed in Cropmate’s business and strategic direction. We are grateful for this overwhelming support and excited to move forward with our plans to enhance our operations and customer service capability to meet the growing demand for our fertilisers.”Mr Lee also added, “The enthusiastic response from investors underscores their belief in Cropmate’s future potential. This support motivates us to strengthen our operations and continue innovating to meet the evolving needs of the agriculture industry.”Group Managing Director/Chief Executive Officer of Hong Leong Investment Bank Berhad (“HLIB”), Ms. Lee Jim Leng, remarked, “The strong demand for Cropmate’s IPO is a testament to the investment community’s recognition of the Company’s solid management team and their prospects. Cropmate is well-positioned to make a meaningful impact in the agricultural sector, and we are honoured to support them in their journey.”Hong Leong Investment Bank Berhad is the Principal Adviser, Sponsor, Underwriter and Bookrunner.Cropmate Berhad is scheduled to make its debut on the ACE Market of Bursa Securities on 5 December 2024.About Cropmate Berhad (“Cropmate”)Founded in 2018, Cropmate Berhad is an established fertiliser manufacturer and supplier in Malaysia, specialising in the formulation and blending of conventional and specialty fertilisers. With a focus on innovation and sustainability, Cropmate offers a wide range of products designed to enhance agricultural productivity, including compacted and blended fertilisers, as well as semi-organic, organic, and liquid fertilisers. Led by industry veterans with decades of experience, Cropmate is committed to supporting farmers in improving crop yield and quality. As the first pure-play fertiliser company listed on Bursa Malaysia, Cropmate continues to advance its mission of contributing to the growth and sustainability of the agricultural sector.For more information, visit https://www.cropmate.com.my/Issued By: Swan Consultancy Sdn. Bhd. on behalf of Cropmate BerhadFor more information, please contact:Jazzmin WanEmail: j.wan@swanconsultancy.bizWilliam YeoEmail: w.yeo@swanconsultancy.biz Copyright 2024 ACN Newswire via SeaPRwire.com.